PRJNA375882: Comprehensive Mouse Transcriptomic BodyMap
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Wrnip1
|
ENSMUSG00000021400.9 | Wrnip1 |
Mta3
|
ENSMUSG00000055817.19 | Mta3 |
Rcor1
|
ENSMUSG00000037896.18 | Rcor1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Wrnip1 | mm39_v1_chr13_+_32985990_32986135 | 0.43 | 1.5e-04 | Click! |
Mta3 | mm39_v1_chr17_+_84013575_84013634 | 0.35 | 3.0e-03 | Click! |
Rcor1 | mm39_v1_chr12_+_111005768_111005834 | 0.03 | 8.0e-01 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr7_+_45349267 | 54.55 |
ENSMUST00000003360.10
|
Car11
|
carbonic anhydrase 11 |
chr2_+_83642910 | 52.77 |
ENSMUST00000051454.4
|
Fam171b
|
family with sequence similarity 171, member B |
chr2_-_180798785 | 42.85 |
ENSMUST00000055990.8
|
Eef1a2
|
eukaryotic translation elongation factor 1 alpha 2 |
chr2_-_180956293 | 41.53 |
ENSMUST00000103045.4
|
Stmn3
|
stathmin-like 3 |
chr13_+_19132375 | 40.46 |
ENSMUST00000239207.2
ENSMUST00000003345.10 ENSMUST00000200466.5 |
Amph
|
amphiphysin |
chr14_-_9184969 | 40.43 |
ENSMUST00000070323.12
|
Synpr
|
synaptoporin |
chr9_-_53882530 | 38.78 |
ENSMUST00000048409.14
|
Elmod1
|
ELMO/CED-12 domain containing 1 |
chr1_-_75240551 | 38.29 |
ENSMUST00000186178.7
ENSMUST00000189769.7 ENSMUST00000027404.12 |
Ptprn
|
protein tyrosine phosphatase, receptor type, N |
chr4_-_129015027 | 38.02 |
ENSMUST00000030572.10
|
Hpca
|
hippocalcin |
chr5_-_108697857 | 37.36 |
ENSMUST00000129040.2
ENSMUST00000046892.10 |
Cplx1
|
complexin 1 |
chr1_+_66214445 | 36.64 |
ENSMUST00000114017.8
ENSMUST00000114015.8 |
Map2
|
microtubule-associated protein 2 |
chr4_-_129015682 | 36.63 |
ENSMUST00000139450.8
ENSMUST00000125931.9 ENSMUST00000116444.10 |
Hpca
|
hippocalcin |
chr17_-_57394718 | 36.48 |
ENSMUST00000071135.6
|
Tubb4a
|
tubulin, beta 4A class IVA |
chr5_-_38316706 | 36.45 |
ENSMUST00000201341.2
ENSMUST00000201363.4 ENSMUST00000201134.2 |
Nsg1
|
neuron specific gene family member 1 |
chr10_-_127099183 | 36.05 |
ENSMUST00000099172.5
|
Kif5a
|
kinesin family member 5A |
chr4_-_129015493 | 35.32 |
ENSMUST00000135763.2
ENSMUST00000149763.3 ENSMUST00000164649.8 |
Hpca
|
hippocalcin |
chr11_-_118800314 | 35.26 |
ENSMUST00000117731.8
ENSMUST00000106278.9 ENSMUST00000120061.8 ENSMUST00000017576.11 |
Rbfox3
|
RNA binding protein, fox-1 homolog (C. elegans) 3 |
chr7_+_3352019 | 35.25 |
ENSMUST00000100301.11
|
Prkcg
|
protein kinase C, gamma |
chr6_-_124746510 | 34.75 |
ENSMUST00000149652.2
ENSMUST00000112476.8 ENSMUST00000004378.15 |
Eno2
|
enolase 2, gamma neuronal |
chr4_+_138181616 | 34.69 |
ENSMUST00000050918.4
|
Camk2n1
|
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
chr2_+_25132941 | 34.20 |
ENSMUST00000114355.2
ENSMUST00000060818.2 |
Rnf208
|
ring finger protein 208 |
chr2_+_118610184 | 33.64 |
ENSMUST00000063975.10
ENSMUST00000037547.9 ENSMUST00000110846.8 ENSMUST00000110843.2 |
Disp2
|
dispatched RND tramsporter family member 2 |
chr6_+_114259596 | 33.16 |
ENSMUST00000032454.8
|
Slc6a1
|
solute carrier family 6 (neurotransmitter transporter, GABA), member 1 |
chr9_+_110075133 | 32.58 |
ENSMUST00000199736.2
|
Cspg5
|
chondroitin sulfate proteoglycan 5 |
chr11_+_78213791 | 32.06 |
ENSMUST00000017534.15
|
Aldoc
|
aldolase C, fructose-bisphosphate |
chr7_-_105230395 | 31.75 |
ENSMUST00000188726.2
ENSMUST00000188440.7 |
Apbb1
|
amyloid beta (A4) precursor protein-binding, family B, member 1 |
chr10_-_127098932 | 31.49 |
ENSMUST00000217895.2
|
Kif5a
|
kinesin family member 5A |
chr15_+_4056103 | 31.44 |
ENSMUST00000138927.2
|
Oxct1
|
3-oxoacid CoA transferase 1 |
chr7_+_3381434 | 31.32 |
ENSMUST00000092891.6
|
Cacng7
|
calcium channel, voltage-dependent, gamma subunit 7 |
chr7_-_100311522 | 31.30 |
ENSMUST00000151123.8
ENSMUST00000208812.2 ENSMUST00000107047.10 |
Plekhb1
|
pleckstrin homology domain containing, family B (evectins) member 1 |
chr2_-_127498129 | 31.29 |
ENSMUST00000028853.7
|
Mal
|
myelin and lymphocyte protein, T cell differentiation protein |
chr17_-_37334240 | 31.02 |
ENSMUST00000102665.11
|
Mog
|
myelin oligodendrocyte glycoprotein |
chr5_+_107551362 | 30.99 |
ENSMUST00000049146.12
|
Ephx4
|
epoxide hydrolase 4 |
chr8_-_65146079 | 30.79 |
ENSMUST00000048967.9
|
Cpe
|
carboxypeptidase E |
chr2_-_144369261 | 30.73 |
ENSMUST00000163701.2
ENSMUST00000081982.12 |
Dzank1
|
double zinc ribbon and ankyrin repeat domains 1 |
chr7_-_100311621 | 30.21 |
ENSMUST00000079176.14
|
Plekhb1
|
pleckstrin homology domain containing, family B (evectins) member 1 |
chr14_+_55173696 | 30.20 |
ENSMUST00000037814.8
|
Cmtm5
|
CKLF-like MARVEL transmembrane domain containing 5 |
chr2_-_32737238 | 30.15 |
ENSMUST00000050000.16
|
Stxbp1
|
syntaxin binding protein 1 |
chr14_-_57371041 | 29.97 |
ENSMUST00000039380.9
|
Gjb6
|
gap junction protein, beta 6 |
chr3_-_54823287 | 29.97 |
ENSMUST00000070342.4
|
Sertm1
|
serine rich and transmembrane domain containing 1 |
chr5_+_137551774 | 29.36 |
ENSMUST00000136088.8
ENSMUST00000139395.8 |
Actl6b
|
actin-like 6B |
chr8_+_63404228 | 29.35 |
ENSMUST00000118003.8
|
Spock3
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan 3 |
chr7_-_119801327 | 29.26 |
ENSMUST00000033198.6
|
Crym
|
crystallin, mu |
chr7_+_15863679 | 29.21 |
ENSMUST00000211649.2
|
Slc8a2
|
solute carrier family 8 (sodium/calcium exchanger), member 2 |
chr1_-_135095344 | 29.13 |
ENSMUST00000027682.9
|
Gpr37l1
|
G protein-coupled receptor 37-like 1 |
chr2_-_180596469 | 28.84 |
ENSMUST00000148905.8
ENSMUST00000103053.10 ENSMUST00000108873.9 |
Nkain4
|
Na+/K+ transporting ATPase interacting 4 |
chr7_+_49624978 | 28.79 |
ENSMUST00000107603.2
|
Nell1
|
NEL-like 1 |
chr8_+_63404395 | 28.76 |
ENSMUST00000119068.8
|
Spock3
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan 3 |
chr2_+_164802766 | 28.34 |
ENSMUST00000202223.4
|
Slc12a5
|
solute carrier family 12, member 5 |
chr2_+_27332336 | 28.11 |
ENSMUST00000209765.2
|
Brd3os
|
bromodomain containing 3, opposite strand |
chr7_-_126548671 | 27.64 |
ENSMUST00000106339.2
ENSMUST00000052937.12 |
Asphd1
|
aspartate beta-hydroxylase domain containing 1 |
chr12_+_58258558 | 27.46 |
ENSMUST00000110671.3
ENSMUST00000044299.3 |
Sstr1
|
somatostatin receptor 1 |
chr1_-_135302971 | 27.39 |
ENSMUST00000041240.4
|
Shisa4
|
shisa family member 4 |
chr12_-_4891435 | 27.31 |
ENSMUST00000219880.2
ENSMUST00000020964.7 |
Fkbp1b
|
FK506 binding protein 1b |
chr18_-_74197970 | 27.18 |
ENSMUST00000159162.2
ENSMUST00000091851.10 |
Mapk4
|
mitogen-activated protein kinase 4 |
chr16_+_41353360 | 26.97 |
ENSMUST00000099761.10
|
Lsamp
|
limbic system-associated membrane protein |
chr14_-_68362284 | 26.93 |
ENSMUST00000111089.8
ENSMUST00000022638.6 |
Nefm
|
neurofilament, medium polypeptide |
chr14_-_29443792 | 26.93 |
ENSMUST00000022567.9
|
Cacna2d3
|
calcium channel, voltage-dependent, alpha2/delta subunit 3 |
chr5_+_125609440 | 26.87 |
ENSMUST00000031446.7
|
Tmem132b
|
transmembrane protein 132B |
chr1_-_132669490 | 26.75 |
ENSMUST00000094569.11
ENSMUST00000163770.8 ENSMUST00000188307.2 |
Nfasc
|
neurofascin |
chr2_+_164802729 | 26.72 |
ENSMUST00000202623.4
|
Slc12a5
|
solute carrier family 12, member 5 |
chr2_+_28095660 | 26.70 |
ENSMUST00000102879.4
ENSMUST00000028177.11 |
Olfm1
|
olfactomedin 1 |
chr11_+_56902658 | 26.60 |
ENSMUST00000094179.11
|
Gria1
|
glutamate receptor, ionotropic, AMPA1 (alpha 1) |
chr4_+_123077515 | 26.57 |
ENSMUST00000152194.2
|
Hpcal4
|
hippocalcin-like 4 |
chrX_-_94209913 | 26.52 |
ENSMUST00000113873.9
ENSMUST00000113876.9 ENSMUST00000199920.5 ENSMUST00000113885.8 ENSMUST00000113883.8 ENSMUST00000196012.2 ENSMUST00000182001.8 ENSMUST00000113878.8 ENSMUST00000113882.8 ENSMUST00000182562.2 |
Arhgef9
|
CDC42 guanine nucleotide exchange factor (GEF) 9 |
chr12_-_76869282 | 26.48 |
ENSMUST00000021459.14
|
Rab15
|
RAB15, member RAS oncogene family |
chr1_-_93029532 | 26.40 |
ENSMUST00000171796.8
|
Kif1a
|
kinesin family member 1A |
chr17_-_37334091 | 26.30 |
ENSMUST00000167275.3
|
Mog
|
myelin oligodendrocyte glycoprotein |
chr13_+_104246259 | 26.18 |
ENSMUST00000160322.8
ENSMUST00000159574.2 |
Sgtb
|
small glutamine-rich tetratricopeptide repeat (TPR)-containing, beta |
chr1_-_93029547 | 26.00 |
ENSMUST00000112958.9
ENSMUST00000186861.2 ENSMUST00000171556.8 |
Kif1a
|
kinesin family member 1A |
chr14_+_70694887 | 25.89 |
ENSMUST00000003561.10
|
Phyhip
|
phytanoyl-CoA hydroxylase interacting protein |
chr9_+_43957241 | 25.80 |
ENSMUST00000214627.2
|
Thy1
|
thymus cell antigen 1, theta |
chr13_-_100037149 | 25.80 |
ENSMUST00000022150.8
|
Cartpt
|
CART prepropeptide |
chr15_+_38740784 | 25.50 |
ENSMUST00000226440.3
ENSMUST00000239553.1 |
Baalc
|
brain and acute leukemia, cytoplasmic |
chr2_-_151474391 | 25.43 |
ENSMUST00000137936.2
ENSMUST00000146172.8 ENSMUST00000094456.10 ENSMUST00000148755.8 ENSMUST00000109875.8 ENSMUST00000028951.14 ENSMUST00000109877.10 |
Snph
|
syntaphilin |
chrX_+_135567124 | 25.36 |
ENSMUST00000060904.11
ENSMUST00000113100.2 ENSMUST00000128040.2 |
Tceal3
|
transcription elongation factor A (SII)-like 3 |
chr1_-_171023798 | 25.33 |
ENSMUST00000111332.2
|
Pcp4l1
|
Purkinje cell protein 4-like 1 |
chr4_-_139974062 | 25.29 |
ENSMUST00000039331.9
|
Igsf21
|
immunoglobulin superfamily, member 21 |
chr7_+_19016536 | 25.27 |
ENSMUST00000032559.17
|
Rtn2
|
reticulon 2 (Z-band associated protein) |
chr15_-_99425555 | 25.27 |
ENSMUST00000231171.2
|
Faim2
|
Fas apoptotic inhibitory molecule 2 |
chr15_+_98530236 | 25.24 |
ENSMUST00000109150.9
|
Cacnb3
|
calcium channel, voltage-dependent, beta 3 subunit |
chr10_-_67748461 | 25.22 |
ENSMUST00000064656.8
|
Zfp365
|
zinc finger protein 365 |
chr9_-_86762467 | 25.21 |
ENSMUST00000074501.12
ENSMUST00000239074.2 ENSMUST00000098495.10 ENSMUST00000036347.13 ENSMUST00000074468.13 |
Snap91
|
synaptosomal-associated protein 91 |
chr6_+_115111872 | 25.07 |
ENSMUST00000009538.12
ENSMUST00000203450.2 |
Syn2
|
synapsin II |
chr7_+_4925781 | 24.78 |
ENSMUST00000207527.2
ENSMUST00000207687.2 ENSMUST00000208754.2 |
Nat14
|
N-acetyltransferase 14 |
chr13_+_104246245 | 24.76 |
ENSMUST00000044385.14
|
Sgtb
|
small glutamine-rich tetratricopeptide repeat (TPR)-containing, beta |
chr1_-_172034251 | 24.70 |
ENSMUST00000155109.2
|
Pea15a
|
phosphoprotein enriched in astrocytes 15A |
chr17_+_26028059 | 24.63 |
ENSMUST00000045692.9
|
Fbxl16
|
F-box and leucine-rich repeat protein 16 |
chr3_-_87907537 | 24.52 |
ENSMUST00000090971.11
|
Bcan
|
brevican |
chr10_+_76089674 | 24.49 |
ENSMUST00000036387.8
|
S100b
|
S100 protein, beta polypeptide, neural |
chr4_-_68872585 | 24.49 |
ENSMUST00000030036.6
|
Brinp1
|
bone morphogenic protein/retinoic acid inducible neural specific 1 |
chr7_-_105230479 | 24.49 |
ENSMUST00000191601.7
|
Apbb1
|
amyloid beta (A4) precursor protein-binding, family B, member 1 |
chr9_+_58395850 | 24.39 |
ENSMUST00000085658.5
|
Insyn1
|
inhibitory synaptic factor 1 |
chr2_+_143388062 | 24.25 |
ENSMUST00000028905.10
|
Pcsk2
|
proprotein convertase subtilisin/kexin type 2 |
chr7_-_100581314 | 24.24 |
ENSMUST00000107032.3
|
Arhgef17
|
Rho guanine nucleotide exchange factor (GEF) 17 |
chr6_-_24956296 | 24.13 |
ENSMUST00000127247.4
|
Tmem229a
|
transmembrane protein 229A |
chr15_+_4055865 | 24.13 |
ENSMUST00000110690.9
|
Oxct1
|
3-oxoacid CoA transferase 1 |
chr3_+_156267429 | 24.12 |
ENSMUST00000074015.11
|
Negr1
|
neuronal growth regulator 1 |
chr14_+_55173936 | 24.07 |
ENSMUST00000227441.2
|
Cmtm5
|
CKLF-like MARVEL transmembrane domain containing 5 |
chr5_+_66833434 | 23.98 |
ENSMUST00000031131.11
|
Uchl1
|
ubiquitin carboxy-terminal hydrolase L1 |
chrX_+_10351360 | 23.92 |
ENSMUST00000076354.13
ENSMUST00000115526.2 |
Tspan7
|
tetraspanin 7 |
chr1_-_172125555 | 23.91 |
ENSMUST00000085913.11
ENSMUST00000097464.4 |
Atp1a2
|
ATPase, Na+/K+ transporting, alpha 2 polypeptide |
chr11_+_69231589 | 23.88 |
ENSMUST00000218008.2
ENSMUST00000151617.3 |
Rnf227
|
ring finger protein 227 |
chr1_+_132808011 | 23.75 |
ENSMUST00000027706.4
|
Lrrn2
|
leucine rich repeat protein 2, neuronal |
chr1_+_50966670 | 23.69 |
ENSMUST00000081851.4
|
Tmeff2
|
transmembrane protein with EGF-like and two follistatin-like domains 2 |
chrX_+_165127688 | 23.51 |
ENSMUST00000112223.8
ENSMUST00000112224.8 ENSMUST00000112229.9 ENSMUST00000112228.8 ENSMUST00000112227.9 ENSMUST00000112226.3 |
Gpm6b
|
glycoprotein m6b |
chr7_-_81143631 | 23.49 |
ENSMUST00000082090.15
|
Ap3b2
|
adaptor-related protein complex 3, beta 2 subunit |
chr9_+_102988940 | 23.49 |
ENSMUST00000189134.2
ENSMUST00000035155.8 |
Rab6b
|
RAB6B, member RAS oncogene family |
chr5_+_37332834 | 23.48 |
ENSMUST00000208827.2
ENSMUST00000207619.2 |
Gm1043
|
predicted gene 1043 |
chr9_+_58489523 | 23.38 |
ENSMUST00000177292.8
ENSMUST00000085651.12 ENSMUST00000176557.8 ENSMUST00000114121.11 ENSMUST00000177064.8 |
Nptn
|
neuroplastin |
chr9_+_75221415 | 23.30 |
ENSMUST00000215875.2
|
Gnb5
|
guanine nucleotide binding protein (G protein), beta 5 |
chr7_+_30463175 | 23.25 |
ENSMUST00000165887.8
ENSMUST00000085691.11 ENSMUST00000054427.13 ENSMUST00000085688.11 |
Dmkn
|
dermokine |
chr17_-_24908874 | 23.23 |
ENSMUST00000007236.5
|
Syngr3
|
synaptogyrin 3 |
chr2_-_180776920 | 23.19 |
ENSMUST00000197015.5
ENSMUST00000103050.10 ENSMUST00000081528.13 ENSMUST00000049792.15 ENSMUST00000103048.10 ENSMUST00000103047.10 ENSMUST00000149964.9 |
Kcnq2
|
potassium voltage-gated channel, subfamily Q, member 2 |
chr5_-_139115914 | 23.19 |
ENSMUST00000129851.8
|
Prkar1b
|
protein kinase, cAMP dependent regulatory, type I beta |
chr8_+_96404713 | 23.18 |
ENSMUST00000041318.14
|
Ndrg4
|
N-myc downstream regulated gene 4 |
chr7_+_40547608 | 23.17 |
ENSMUST00000044705.12
|
Vstm2b
|
V-set and transmembrane domain containing 2B |
chr14_-_57370706 | 23.08 |
ENSMUST00000160703.2
|
Gjb6
|
gap junction protein, beta 6 |
chr8_-_70939964 | 22.70 |
ENSMUST00000045286.9
|
Tmem59l
|
transmembrane protein 59-like |
chr14_+_68321302 | 22.65 |
ENSMUST00000022639.8
|
Nefl
|
neurofilament, light polypeptide |
chr7_+_34885782 | 22.60 |
ENSMUST00000135452.8
ENSMUST00000001854.12 |
Slc7a10
|
solute carrier family 7 (cationic amino acid transporter, y+ system), member 10 |
chr2_+_70393195 | 22.58 |
ENSMUST00000130998.8
|
Gad1
|
glutamate decarboxylase 1 |
chr3_+_55149947 | 22.57 |
ENSMUST00000167204.8
ENSMUST00000054237.14 |
Dclk1
|
doublecortin-like kinase 1 |
chr14_-_55354392 | 22.49 |
ENSMUST00000022819.13
|
Jph4
|
junctophilin 4 |
chr9_+_8900460 | 22.47 |
ENSMUST00000070463.10
ENSMUST00000098986.4 |
Pgr
|
progesterone receptor |
chr5_-_38316296 | 22.42 |
ENSMUST00000201415.4
|
Nsg1
|
neuron specific gene family member 1 |
chr6_-_36787096 | 22.39 |
ENSMUST00000201321.2
ENSMUST00000101534.5 |
Ptn
|
pleiotrophin |
chr15_-_37792237 | 22.37 |
ENSMUST00000168992.8
ENSMUST00000148652.9 |
Ncald
|
neurocalcin delta |
chr11_+_56902624 | 22.36 |
ENSMUST00000036315.16
|
Gria1
|
glutamate receptor, ionotropic, AMPA1 (alpha 1) |
chr6_-_124840824 | 22.33 |
ENSMUST00000046893.10
ENSMUST00000204667.2 |
Gpr162
|
G protein-coupled receptor 162 |
chr2_-_170269748 | 22.32 |
ENSMUST00000013667.3
ENSMUST00000109152.9 ENSMUST00000068137.11 |
Bcas1
|
breast carcinoma amplified sequence 1 |
chr1_-_5089564 | 22.29 |
ENSMUST00000002533.15
|
Rgs20
|
regulator of G-protein signaling 20 |
chr2_+_158452651 | 22.24 |
ENSMUST00000045738.5
|
Slc32a1
|
solute carrier family 32 (GABA vesicular transporter), member 1 |
chr9_+_27702243 | 22.18 |
ENSMUST00000115243.9
|
Opcml
|
opioid binding protein/cell adhesion molecule-like |
chr11_+_101066867 | 22.18 |
ENSMUST00000103109.4
|
Cntnap1
|
contactin associated protein-like 1 |
chr1_-_77491683 | 22.12 |
ENSMUST00000186930.2
ENSMUST00000027451.13 ENSMUST00000188797.7 |
Epha4
|
Eph receptor A4 |
chr6_+_22875494 | 22.12 |
ENSMUST00000090568.7
|
Ptprz1
|
protein tyrosine phosphatase, receptor type Z, polypeptide 1 |
chrX_-_151820545 | 22.10 |
ENSMUST00000051484.5
|
Mageh1
|
MAGE family member H1 |
chr7_+_143838149 | 22.00 |
ENSMUST00000146006.3
|
Shank2
|
SH3 and multiple ankyrin repeat domains 2 |
chr3_+_82265351 | 21.99 |
ENSMUST00000193559.6
ENSMUST00000192595.6 ENSMUST00000091014.10 |
Map9
|
microtubule-associated protein 9 |
chrX_-_72703330 | 21.88 |
ENSMUST00000114473.8
ENSMUST00000002087.14 |
Pnck
|
pregnancy upregulated non-ubiquitously expressed CaM kinase |
chrX_+_80114242 | 21.85 |
ENSMUST00000171953.8
ENSMUST00000026760.3 |
Tmem47
|
transmembrane protein 47 |
chr7_+_111825063 | 21.76 |
ENSMUST00000050149.12
|
Mical2
|
microtubule associated monooxygenase, calponin and LIM domain containing 2 |
chr2_+_70393782 | 21.69 |
ENSMUST00000123330.3
|
Gad1
|
glutamate decarboxylase 1 |
chr3_+_8574420 | 21.66 |
ENSMUST00000029002.9
|
Stmn2
|
stathmin-like 2 |
chr5_+_135052336 | 21.60 |
ENSMUST00000005509.11
ENSMUST00000201008.4 |
Stx1a
|
syntaxin 1A (brain) |
chr5_-_18565353 | 21.60 |
ENSMUST00000074694.7
|
Gnai1
|
guanine nucleotide binding protein (G protein), alpha inhibiting 1 |
chr7_+_29991101 | 21.55 |
ENSMUST00000150892.2
ENSMUST00000126216.2 ENSMUST00000014065.16 |
Clip3
|
CAP-GLY domain containing linker protein 3 |
chr2_+_134627987 | 21.53 |
ENSMUST00000131552.5
ENSMUST00000110116.8 |
Plcb1
|
phospholipase C, beta 1 |
chr17_+_21165573 | 21.46 |
ENSMUST00000007708.14
|
Ppp2r1a
|
protein phosphatase 2, regulatory subunit A, alpha |
chr6_-_124745294 | 21.39 |
ENSMUST00000135626.8
|
Eno2
|
enolase 2, gamma neuronal |
chr2_-_25360043 | 21.31 |
ENSMUST00000114251.8
|
Ptgds
|
prostaglandin D2 synthase (brain) |
chr9_-_83688294 | 21.24 |
ENSMUST00000034796.14
ENSMUST00000183614.2 |
Elovl4
|
elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 4 |
chr1_-_38875757 | 21.24 |
ENSMUST00000147695.9
|
Lonrf2
|
LON peptidase N-terminal domain and ring finger 2 |
chr1_-_87438027 | 21.23 |
ENSMUST00000027477.15
|
Ngef
|
neuronal guanine nucleotide exchange factor |
chr1_+_66214431 | 21.22 |
ENSMUST00000156636.9
|
Map2
|
microtubule-associated protein 2 |
chr9_-_57513510 | 21.21 |
ENSMUST00000215487.2
ENSMUST00000045068.10 |
Cplx3
|
complexin 3 |
chr1_-_173161069 | 21.21 |
ENSMUST00000038227.6
|
Ackr1
|
atypical chemokine receptor 1 (Duffy blood group) |
chr6_-_124746468 | 21.07 |
ENSMUST00000204896.3
|
Eno2
|
enolase 2, gamma neuronal |
chr4_-_148372384 | 21.05 |
ENSMUST00000047720.9
|
Disp3
|
dispatched RND transporter family member 3 |
chr5_-_71253107 | 21.04 |
ENSMUST00000197284.5
|
Gabra2
|
gamma-aminobutyric acid (GABA) A receptor, subunit alpha 2 |
chr2_-_152218542 | 21.03 |
ENSMUST00000079278.5
|
Nrsn2
|
neurensin 2 |
chr16_+_39804711 | 21.01 |
ENSMUST00000187695.7
|
Lsamp
|
limbic system-associated membrane protein |
chr9_+_109760856 | 20.98 |
ENSMUST00000169851.8
|
Map4
|
microtubule-associated protein 4 |
chr3_-_107425316 | 20.98 |
ENSMUST00000169449.8
ENSMUST00000029499.15 |
Slc6a17
|
solute carrier family 6 (neurotransmitter transporter), member 17 |
chr5_+_37025810 | 20.97 |
ENSMUST00000031003.11
|
Ppp2r2c
|
protein phosphatase 2, regulatory subunit B, gamma |
chr7_+_126422458 | 20.97 |
ENSMUST00000079423.7
|
Tlcd3b
|
TLC domain containing 3B |
chr9_+_107812873 | 20.88 |
ENSMUST00000035700.14
|
Camkv
|
CaM kinase-like vesicle-associated |
chrX_+_134894573 | 20.87 |
ENSMUST00000058119.9
|
Arxes2
|
adipocyte-related X-chromosome expressed sequence 2 |
chr17_+_70276382 | 20.83 |
ENSMUST00000146730.9
|
Dlgap1
|
DLG associated protein 1 |
chr2_+_121189091 | 20.82 |
ENSMUST00000000317.13
ENSMUST00000129130.3 |
Ckmt1
|
creatine kinase, mitochondrial 1, ubiquitous |
chr2_+_121188195 | 20.82 |
ENSMUST00000125812.8
ENSMUST00000078222.9 ENSMUST00000125221.3 ENSMUST00000150271.8 |
Ckmt1
|
creatine kinase, mitochondrial 1, ubiquitous |
chr7_-_100306160 | 20.79 |
ENSMUST00000107046.8
ENSMUST00000107045.9 ENSMUST00000139708.9 |
Plekhb1
|
pleckstrin homology domain containing, family B (evectins) member 1 |
chr2_-_32737208 | 20.78 |
ENSMUST00000077458.7
ENSMUST00000208840.2 |
Stxbp1
|
syntaxin binding protein 1 |
chr8_+_96429665 | 20.75 |
ENSMUST00000073139.14
ENSMUST00000080666.8 ENSMUST00000212160.2 |
Ndrg4
|
N-myc downstream regulated gene 4 |
chr3_+_105611915 | 20.67 |
ENSMUST00000066610.8
|
Inka2
|
inka box actin regulator 2 |
chr5_-_128897086 | 20.61 |
ENSMUST00000198941.5
ENSMUST00000199537.5 |
Rimbp2
|
RIMS binding protein 2 |
chr8_+_114932312 | 20.60 |
ENSMUST00000049509.7
ENSMUST00000150963.2 |
Vat1l
|
vesicle amine transport protein 1 like |
chr2_+_49509288 | 20.57 |
ENSMUST00000028102.14
|
Kif5c
|
kinesin family member 5C |
chr11_-_74413564 | 20.52 |
ENSMUST00000208896.2
|
Rap1gap2
|
RAP1 GTPase activating protein 2 |
chr7_+_15864265 | 20.51 |
ENSMUST00000168693.3
|
Slc8a2
|
solute carrier family 8 (sodium/calcium exchanger), member 2 |
chr15_-_84331236 | 20.47 |
ENSMUST00000080751.10
ENSMUST00000239449.2 |
Shisal1
|
shisa like 1 |
chr18_-_89787603 | 20.44 |
ENSMUST00000097495.5
|
Dok6
|
docking protein 6 |
chr1_-_93029576 | 20.43 |
ENSMUST00000190723.7
|
Kif1a
|
kinesin family member 1A |
chr1_-_16589511 | 20.41 |
ENSMUST00000162751.8
ENSMUST00000027052.13 ENSMUST00000149320.9 |
Stau2
|
staufen double-stranded RNA binding protein 2 |
chr17_+_8559539 | 20.40 |
ENSMUST00000163887.2
|
Prr18
|
proline rich 18 |
chr17_+_81251997 | 20.39 |
ENSMUST00000025092.5
|
Tmem178
|
transmembrane protein 178 |
chr1_+_74894069 | 20.37 |
ENSMUST00000160379.4
|
Cdk5r2
|
cyclin-dependent kinase 5, regulatory subunit 2 (p39) |
chr8_+_123844090 | 20.33 |
ENSMUST00000037900.9
|
Cpne7
|
copine VII |
chr7_+_44078366 | 20.32 |
ENSMUST00000127790.8
|
Lrrc4b
|
leucine rich repeat containing 4B |
chr15_-_98707367 | 20.27 |
ENSMUST00000230409.2
|
Ddn
|
dendrin |
chr6_-_142453531 | 20.22 |
ENSMUST00000134191.3
ENSMUST00000239397.2 ENSMUST00000239395.2 ENSMUST00000032373.12 |
Ldhb
|
lactate dehydrogenase B |
chr7_+_57240894 | 20.20 |
ENSMUST00000039697.14
|
Gabrb3
|
gamma-aminobutyric acid (GABA) A receptor, subunit beta 3 |
chr18_+_61096660 | 20.19 |
ENSMUST00000039904.7
|
Camk2a
|
calcium/calmodulin-dependent protein kinase II alpha |
chr3_-_72964276 | 20.08 |
ENSMUST00000192477.2
|
Slitrk3
|
SLIT and NTRK-like family, member 3 |
chr10_+_126914755 | 20.05 |
ENSMUST00000039259.7
ENSMUST00000217941.2 |
Agap2
|
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 |
chr6_+_29396574 | 20.03 |
ENSMUST00000115275.8
ENSMUST00000145310.8 ENSMUST00000096084.12 |
Ccdc136
|
coiled-coil domain containing 136 |
chr15_+_76544763 | 20.01 |
ENSMUST00000004294.12
|
Kifc2
|
kinesin family member C2 |
chrX_+_70093766 | 19.97 |
ENSMUST00000239162.2
ENSMUST00000114629.4 ENSMUST00000082088.10 |
Mamld1
|
mastermind-like domain containing 1 |
chr8_-_112120442 | 19.93 |
ENSMUST00000038475.9
|
Fa2h
|
fatty acid 2-hydroxylase |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
36.7 | 110.0 | GO:0030824 | negative regulation of cGMP metabolic process(GO:0030824) negative regulation of cGMP biosynthetic process(GO:0030827) negative regulation of guanylate cyclase activity(GO:0031283) |
20.5 | 61.6 | GO:0040040 | thermosensory behavior(GO:0040040) |
20.4 | 122.5 | GO:0050757 | thymidylate synthase biosynthetic process(GO:0050757) regulation of thymidylate synthase biosynthetic process(GO:0050758) negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
18.7 | 74.9 | GO:0098964 | dendritic transport of ribonucleoprotein complex(GO:0098961) dendritic transport of messenger ribonucleoprotein complex(GO:0098963) anterograde dendritic transport of messenger ribonucleoprotein complex(GO:0098964) |
18.6 | 55.8 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
16.1 | 96.6 | GO:0099525 | presynaptic dense core granule exocytosis(GO:0099525) |
15.8 | 47.4 | GO:0021966 | corticospinal neuron axon guidance(GO:0021966) |
15.5 | 77.6 | GO:0098971 | anterograde dendritic transport of neurotransmitter receptor complex(GO:0098971) |
15.4 | 30.8 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
15.3 | 45.9 | GO:0060466 | activation of meiosis involved in egg activation(GO:0060466) |
13.7 | 41.1 | GO:0030070 | insulin processing(GO:0030070) |
13.2 | 92.7 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
13.0 | 78.3 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
12.9 | 38.8 | GO:0071874 | cellular response to norepinephrine stimulus(GO:0071874) |
12.4 | 49.4 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
12.3 | 12.3 | GO:1900275 | negative regulation of phospholipase C activity(GO:1900275) |
11.9 | 47.6 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
11.6 | 69.6 | GO:0035585 | calcium-mediated signaling using extracellular calcium source(GO:0035585) |
11.4 | 45.7 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
11.3 | 124.3 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
11.3 | 45.2 | GO:0051866 | general adaptation syndrome(GO:0051866) |
11.1 | 33.2 | GO:0045763 | negative regulation of cellular amino acid metabolic process(GO:0045763) |
11.0 | 54.8 | GO:0061642 | chemoattraction of axon(GO:0061642) |
10.9 | 76.3 | GO:0016198 | axon choice point recognition(GO:0016198) |
10.9 | 43.6 | GO:1904708 | granulosa cell apoptotic process(GO:1904700) regulation of granulosa cell apoptotic process(GO:1904708) |
10.9 | 97.9 | GO:0098885 | modification of postsynaptic actin cytoskeleton(GO:0098885) |
10.8 | 43.3 | GO:0007412 | axon target recognition(GO:0007412) |
10.8 | 43.1 | GO:1900149 | positive regulation of Schwann cell migration(GO:1900149) |
10.7 | 96.7 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
10.6 | 10.6 | GO:0010593 | negative regulation of lamellipodium assembly(GO:0010593) |
10.5 | 73.5 | GO:1990034 | calcium ion export from cell(GO:1990034) |
10.4 | 41.8 | GO:0046959 | habituation(GO:0046959) |
10.2 | 81.5 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) negative regulation of serotonin uptake(GO:0051612) |
10.2 | 81.4 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
10.2 | 30.5 | GO:0015825 | L-serine transport(GO:0015825) |
9.9 | 29.7 | GO:1903288 | positive regulation of potassium ion import(GO:1903288) |
9.8 | 39.2 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
9.8 | 58.8 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
9.7 | 58.3 | GO:2001023 | regulation of response to drug(GO:2001023) |
9.6 | 38.3 | GO:0035934 | corticosterone secretion(GO:0035934) |
9.4 | 9.4 | GO:1902996 | neurofibrillary tangle assembly(GO:1902988) regulation of neurofibrillary tangle assembly(GO:1902996) |
9.4 | 65.5 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
9.3 | 37.1 | GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
9.2 | 45.9 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
9.2 | 45.9 | GO:0061744 | motor behavior(GO:0061744) |
8.9 | 26.7 | GO:0021589 | hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
8.9 | 222.3 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
8.9 | 53.2 | GO:0032423 | regulation of mismatch repair(GO:0032423) |
8.8 | 26.4 | GO:0097156 | fasciculation of motor neuron axon(GO:0097156) |
8.7 | 104.4 | GO:0023041 | neuronal signal transduction(GO:0023041) |
8.7 | 60.7 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
8.6 | 34.5 | GO:0051582 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
8.6 | 25.7 | GO:0061107 | seminal vesicle development(GO:0061107) |
8.6 | 8.6 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
8.6 | 8.6 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
8.6 | 8.6 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
8.5 | 42.6 | GO:0098828 | modulation of inhibitory postsynaptic potential(GO:0098828) |
8.5 | 34.0 | GO:0021586 | pons maturation(GO:0021586) |
8.5 | 17.0 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
8.5 | 25.4 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
8.3 | 25.0 | GO:0099552 | trans-synaptic signaling by lipid, modulating synaptic transmission(GO:0099552) trans-synaptic signaling by endocannabinoid, modulating synaptic transmission(GO:0099553) |
8.3 | 24.9 | GO:1903537 | meiotic cell cycle process involved in oocyte maturation(GO:1903537) regulation of meiotic cell cycle process involved in oocyte maturation(GO:1903538) |
8.2 | 41.1 | GO:0046952 | ketone body catabolic process(GO:0046952) |
8.1 | 48.5 | GO:0098712 | L-glutamate import across plasma membrane(GO:0098712) |
8.1 | 121.0 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
8.0 | 64.2 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
8.0 | 80.2 | GO:0098887 | neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) |
8.0 | 24.0 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
7.9 | 31.6 | GO:0021933 | radial glia guided migration of cerebellar granule cell(GO:0021933) |
7.9 | 39.3 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
7.8 | 23.5 | GO:0030800 | negative regulation of cyclic nucleotide metabolic process(GO:0030800) |
7.8 | 15.6 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
7.8 | 23.4 | GO:0050976 | detection of mechanical stimulus involved in sensory perception of touch(GO:0050976) |
7.8 | 31.0 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
7.7 | 23.2 | GO:0035544 | negative regulation of SNARE complex assembly(GO:0035544) |
7.7 | 15.3 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
7.6 | 22.8 | GO:0001661 | conditioned taste aversion(GO:0001661) |
7.6 | 45.6 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
7.6 | 30.3 | GO:1901660 | calcium ion export(GO:1901660) |
7.6 | 83.1 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
7.5 | 60.4 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
7.5 | 22.6 | GO:1904020 | regulation of G-protein coupled receptor internalization(GO:1904020) |
7.5 | 82.5 | GO:1902473 | regulation of protein localization to synapse(GO:1902473) |
7.5 | 112.0 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
7.4 | 37.2 | GO:0032901 | positive regulation of neurotrophin production(GO:0032901) |
7.4 | 29.6 | GO:1903575 | cornified envelope assembly(GO:1903575) |
7.4 | 36.8 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
7.3 | 29.3 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
7.2 | 7.2 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
7.2 | 21.5 | GO:0019417 | sulfur oxidation(GO:0019417) |
7.1 | 21.3 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
7.0 | 7.0 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
7.0 | 7.0 | GO:0050975 | sensory perception of touch(GO:0050975) |
7.0 | 7.0 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
7.0 | 34.9 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
7.0 | 20.9 | GO:2000536 | negative regulation of entry of bacterium into host cell(GO:2000536) |
7.0 | 27.8 | GO:0070099 | regulation of chemokine-mediated signaling pathway(GO:0070099) |
6.9 | 13.9 | GO:0035483 | gastric emptying(GO:0035483) |
6.9 | 48.5 | GO:0007258 | JUN phosphorylation(GO:0007258) |
6.9 | 34.6 | GO:0001830 | trophectodermal cell fate commitment(GO:0001830) |
6.9 | 165.5 | GO:0035640 | exploration behavior(GO:0035640) |
6.9 | 6.9 | GO:1990379 | lipid transport across blood brain barrier(GO:1990379) |
6.9 | 54.8 | GO:0009405 | pathogenesis(GO:0009405) |
6.8 | 33.8 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
6.7 | 20.1 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
6.7 | 40.2 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
6.7 | 40.1 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
6.7 | 26.7 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
6.6 | 26.5 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
6.6 | 32.9 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
6.6 | 6.6 | GO:1901662 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
6.5 | 13.1 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
6.5 | 19.6 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
6.5 | 26.1 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
6.5 | 6.5 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
6.5 | 149.3 | GO:0071420 | cellular response to histamine(GO:0071420) |
6.5 | 12.9 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
6.4 | 6.4 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
6.4 | 25.5 | GO:0098886 | modification of dendritic spine(GO:0098886) |
6.3 | 82.4 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
6.3 | 6.3 | GO:1904959 | regulation of cytochrome-c oxidase activity(GO:1904959) |
6.3 | 25.0 | GO:1904395 | positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
6.2 | 24.8 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
6.2 | 37.1 | GO:0051938 | L-glutamate import(GO:0051938) |
6.2 | 18.5 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
6.2 | 6.2 | GO:1904339 | negative regulation of dopaminergic neuron differentiation(GO:1904339) |
6.1 | 12.3 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
6.1 | 24.6 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
6.1 | 18.4 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
6.0 | 30.0 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
6.0 | 23.9 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
6.0 | 101.7 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
6.0 | 131.5 | GO:0008038 | neuron recognition(GO:0008038) |
5.9 | 5.9 | GO:0051542 | elastin biosynthetic process(GO:0051542) |
5.9 | 29.5 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
5.9 | 17.6 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
5.9 | 17.6 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
5.8 | 17.5 | GO:0072720 | response to dithiothreitol(GO:0072720) |
5.8 | 64.2 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
5.8 | 17.4 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
5.8 | 17.4 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
5.8 | 34.5 | GO:0014005 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
5.7 | 34.5 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
5.7 | 51.6 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
5.7 | 34.2 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
5.7 | 22.8 | GO:1904529 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
5.7 | 62.2 | GO:0032291 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
5.6 | 5.6 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
5.6 | 67.5 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
5.6 | 22.4 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
5.6 | 22.3 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
5.5 | 11.1 | GO:0015870 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
5.5 | 16.5 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
5.5 | 16.4 | GO:0021823 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) motogenic signaling involved in postnatal olfactory bulb interneuron migration(GO:0021837) positive regulation of mitotic cell cycle DNA replication(GO:1903465) |
5.4 | 16.3 | GO:0036363 | transforming growth factor beta activation(GO:0036363) |
5.4 | 5.4 | GO:1901003 | negative regulation of fermentation(GO:1901003) |
5.4 | 16.2 | GO:0046684 | response to pyrethroid(GO:0046684) |
5.4 | 37.8 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
5.4 | 10.8 | GO:1903233 | regulation of calcium ion-dependent exocytosis of neurotransmitter(GO:1903233) |
5.4 | 32.3 | GO:0099538 | synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signalling, modulating synaptic transmission(GO:0099550) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
5.4 | 69.8 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
5.4 | 43.0 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
5.4 | 53.6 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
5.4 | 32.1 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
5.3 | 37.4 | GO:0051012 | microtubule sliding(GO:0051012) |
5.3 | 63.8 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
5.3 | 79.5 | GO:0048169 | regulation of long-term neuronal synaptic plasticity(GO:0048169) |
5.3 | 5.3 | GO:0001997 | positive regulation of the force of heart contraction by epinephrine-norepinephrine(GO:0001997) positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
5.3 | 31.7 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
5.3 | 42.1 | GO:0038042 | dimeric G-protein coupled receptor signaling pathway(GO:0038042) |
5.3 | 15.8 | GO:0021636 | trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
5.3 | 126.1 | GO:1903831 | acetylcholine receptor signaling pathway(GO:0095500) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
5.2 | 5.2 | GO:0006533 | aspartate catabolic process(GO:0006533) |
5.2 | 15.7 | GO:1905006 | negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905006) |
5.2 | 15.7 | GO:1902277 | negative regulation of pancreatic amylase secretion(GO:1902277) |
5.2 | 83.4 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
5.2 | 25.9 | GO:0036324 | vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
5.2 | 31.1 | GO:0060082 | response to carbon monoxide(GO:0034465) eye blink reflex(GO:0060082) |
5.2 | 15.5 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
5.2 | 15.5 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
5.2 | 103.4 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
5.2 | 541.9 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
5.2 | 10.3 | GO:2000040 | regulation of planar cell polarity pathway involved in axis elongation(GO:2000040) negative regulation of planar cell polarity pathway involved in axis elongation(GO:2000041) |
5.1 | 5.1 | GO:0046958 | nonassociative learning(GO:0046958) |
5.1 | 5.1 | GO:0046834 | lipid phosphorylation(GO:0046834) |
5.1 | 5.1 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
5.1 | 30.6 | GO:0032230 | positive regulation of synaptic transmission, GABAergic(GO:0032230) |
5.1 | 20.3 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
5.1 | 20.3 | GO:1904209 | regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
5.1 | 30.4 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
5.1 | 20.2 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
5.0 | 5.0 | GO:0010996 | response to auditory stimulus(GO:0010996) |
5.0 | 30.1 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
5.0 | 10.0 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
5.0 | 34.8 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
4.9 | 4.9 | GO:0072194 | kidney smooth muscle tissue development(GO:0072194) |
4.9 | 9.8 | GO:1903422 | negative regulation of synaptic vesicle recycling(GO:1903422) |
4.9 | 9.8 | GO:0051892 | negative regulation of cardioblast differentiation(GO:0051892) |
4.9 | 34.4 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
4.9 | 19.6 | GO:1900535 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
4.9 | 161.6 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
4.9 | 14.7 | GO:1904456 | negative regulation of neuronal action potential(GO:1904456) |
4.9 | 4.9 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
4.8 | 87.2 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
4.8 | 19.3 | GO:1902669 | positive regulation of axon guidance(GO:1902669) |
4.8 | 183.3 | GO:0090662 | ATP hydrolysis coupled transmembrane transport(GO:0090662) |
4.8 | 9.6 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
4.8 | 9.6 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
4.8 | 9.6 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
4.7 | 23.6 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
4.7 | 18.8 | GO:0032915 | positive regulation of transforming growth factor beta2 production(GO:0032915) |
4.7 | 4.7 | GO:2000769 | regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000769) positive regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000771) |
4.7 | 187.0 | GO:0016079 | synaptic vesicle exocytosis(GO:0016079) |
4.7 | 28.0 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
4.7 | 4.7 | GO:0071725 | response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
4.6 | 18.6 | GO:0060988 | lipid tube assembly(GO:0060988) |
4.6 | 4.6 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
4.6 | 13.8 | GO:0019085 | early viral transcription(GO:0019085) |
4.5 | 31.8 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
4.5 | 27.2 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
4.5 | 81.2 | GO:0060292 | long term synaptic depression(GO:0060292) |
4.5 | 9.0 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
4.5 | 40.6 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
4.5 | 13.5 | GO:0042822 | pyridoxal phosphate metabolic process(GO:0042822) |
4.5 | 22.5 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
4.5 | 58.4 | GO:0042053 | regulation of dopamine metabolic process(GO:0042053) |
4.5 | 26.9 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
4.5 | 8.9 | GO:0022028 | tangential migration from the subventricular zone to the olfactory bulb(GO:0022028) |
4.5 | 22.4 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
4.5 | 178.8 | GO:1900449 | regulation of glutamate receptor signaling pathway(GO:1900449) |
4.4 | 4.4 | GO:0061141 | lung ciliated cell differentiation(GO:0061141) |
4.4 | 31.1 | GO:0035106 | operant conditioning(GO:0035106) |
4.4 | 8.9 | GO:0061357 | positive regulation of Wnt protein secretion(GO:0061357) |
4.4 | 22.1 | GO:0010747 | positive regulation of plasma membrane long-chain fatty acid transport(GO:0010747) |
4.4 | 17.6 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
4.4 | 44.1 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
4.4 | 8.8 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
4.4 | 26.3 | GO:0006868 | glutamine transport(GO:0006868) |
4.4 | 17.5 | GO:0098582 | innate vocalization behavior(GO:0098582) |
4.4 | 48.1 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
4.4 | 13.1 | GO:1905161 | protein localization to phagocytic vesicle(GO:1905161) regulation of protein localization to phagocytic vesicle(GO:1905169) positive regulation of protein localization to phagocytic vesicle(GO:1905171) |
4.4 | 13.1 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
4.4 | 4.4 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
4.4 | 65.5 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
4.4 | 17.4 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
4.4 | 4.4 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
4.3 | 8.7 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
4.3 | 34.7 | GO:0060134 | prepulse inhibition(GO:0060134) |
4.3 | 21.6 | GO:0038091 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
4.3 | 25.9 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
4.3 | 4.3 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
4.3 | 17.2 | GO:0002086 | diaphragm contraction(GO:0002086) |
4.3 | 12.9 | GO:0015881 | creatine transport(GO:0015881) |
4.3 | 12.8 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
4.3 | 64.1 | GO:0099612 | protein localization to axon(GO:0099612) |
4.3 | 17.0 | GO:0098909 | regulation of cardiac muscle cell action potential involved in regulation of contraction(GO:0098909) |
4.2 | 8.5 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
4.2 | 4.2 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
4.2 | 29.6 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
4.2 | 8.4 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
4.2 | 4.2 | GO:1901203 | positive regulation of extracellular matrix assembly(GO:1901203) |
4.2 | 12.6 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
4.2 | 8.4 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
4.2 | 8.3 | GO:1901731 | positive regulation of platelet aggregation(GO:1901731) |
4.1 | 53.8 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
4.1 | 53.5 | GO:0070842 | aggresome assembly(GO:0070842) |
4.1 | 61.6 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
4.1 | 24.5 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
4.1 | 20.3 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
4.0 | 8.1 | GO:2001201 | regulation of transforming growth factor-beta secretion(GO:2001201) |
4.0 | 16.1 | GO:2000588 | positive regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000588) |
4.0 | 12.1 | GO:0006500 | N-terminal protein palmitoylation(GO:0006500) |
4.0 | 16.0 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
4.0 | 4.0 | GO:0098935 | dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
4.0 | 27.9 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
4.0 | 15.9 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
4.0 | 11.9 | GO:2000299 | negative regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000299) |
4.0 | 15.8 | GO:0045976 | negative regulation of mitotic cell cycle, embryonic(GO:0045976) |
4.0 | 7.9 | GO:2000820 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
3.9 | 31.6 | GO:0070327 | thyroid hormone transport(GO:0070327) |
3.9 | 31.5 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
3.9 | 3.9 | GO:0060372 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) |
3.9 | 7.8 | GO:0046929 | negative regulation of neurotransmitter secretion(GO:0046929) |
3.9 | 15.6 | GO:0071313 | cellular response to caffeine(GO:0071313) |
3.9 | 7.8 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
3.9 | 7.8 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
3.9 | 3.9 | GO:0072578 | neurotransmitter-gated ion channel clustering(GO:0072578) |
3.9 | 7.7 | GO:0009644 | response to high light intensity(GO:0009644) |
3.9 | 11.6 | GO:0006535 | cysteine biosynthetic process from serine(GO:0006535) |
3.8 | 11.5 | GO:1904528 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) positive regulation of microtubule binding(GO:1904528) |
3.8 | 3.8 | GO:0090004 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
3.8 | 19.0 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
3.8 | 15.1 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
3.8 | 53.0 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
3.8 | 49.2 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
3.8 | 15.1 | GO:0030450 | regulation of complement activation, classical pathway(GO:0030450) |
3.8 | 33.8 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
3.8 | 7.5 | GO:1902938 | regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
3.7 | 3.7 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
3.7 | 22.3 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
3.7 | 14.7 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
3.7 | 7.3 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
3.6 | 14.6 | GO:2000656 | regulation of apolipoprotein binding(GO:2000656) negative regulation of apolipoprotein binding(GO:2000657) |
3.6 | 105.7 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
3.6 | 25.5 | GO:1901909 | diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
3.6 | 3.6 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
3.6 | 18.2 | GO:1902163 | negative regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902163) |
3.6 | 10.9 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
3.6 | 21.8 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
3.6 | 58.1 | GO:0007614 | short-term memory(GO:0007614) |
3.6 | 14.5 | GO:1905053 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
3.6 | 3.6 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
3.6 | 25.3 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
3.6 | 14.4 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
3.6 | 14.4 | GO:0022038 | corpus callosum development(GO:0022038) |
3.6 | 10.8 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
3.6 | 50.3 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
3.6 | 3.6 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) |
3.6 | 46.5 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
3.6 | 7.1 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
3.6 | 17.8 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
3.6 | 46.4 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
3.6 | 46.3 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
3.6 | 135.0 | GO:0008089 | anterograde axonal transport(GO:0008089) |
3.6 | 53.3 | GO:0061001 | regulation of dendritic spine morphogenesis(GO:0061001) |
3.5 | 56.8 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
3.5 | 42.4 | GO:2000576 | positive regulation of microtubule motor activity(GO:2000576) |
3.5 | 14.1 | GO:2000016 | negative regulation of determination of dorsal identity(GO:2000016) |
3.5 | 14.1 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
3.5 | 10.5 | GO:2000777 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
3.5 | 35.1 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
3.5 | 91.1 | GO:0010107 | potassium ion import(GO:0010107) |
3.5 | 3.5 | GO:1900365 | positive regulation of mRNA polyadenylation(GO:1900365) |
3.5 | 17.5 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
3.5 | 7.0 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
3.5 | 24.4 | GO:0000103 | sulfate assimilation(GO:0000103) |
3.5 | 38.3 | GO:0086012 | membrane depolarization during cardiac muscle cell action potential(GO:0086012) |
3.5 | 3.5 | GO:1904526 | regulation of microtubule binding(GO:1904526) |
3.5 | 3.5 | GO:0070650 | actin filament bundle distribution(GO:0070650) |
3.5 | 62.5 | GO:0042220 | response to cocaine(GO:0042220) |
3.5 | 10.4 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
3.4 | 6.9 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
3.4 | 10.3 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
3.4 | 20.6 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
3.4 | 30.9 | GO:0006108 | malate metabolic process(GO:0006108) |
3.4 | 30.9 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
3.4 | 13.7 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
3.4 | 10.3 | GO:0048378 | lateral mesodermal cell fate commitment(GO:0048372) lateral mesodermal cell fate specification(GO:0048377) regulation of lateral mesodermal cell fate specification(GO:0048378) |
3.4 | 10.2 | GO:0031590 | wybutosine metabolic process(GO:0031590) wybutosine biosynthetic process(GO:0031591) |
3.4 | 10.1 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
3.4 | 3.4 | GO:0045112 | integrin biosynthetic process(GO:0045112) |
3.4 | 77.3 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
3.4 | 13.4 | GO:0006538 | glutamate catabolic process(GO:0006538) |
3.4 | 53.6 | GO:0060074 | synapse maturation(GO:0060074) |
3.3 | 13.4 | GO:0006529 | asparagine biosynthetic process(GO:0006529) |
3.3 | 36.6 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
3.3 | 3.3 | GO:0003383 | apical constriction(GO:0003383) |
3.3 | 26.6 | GO:0086098 | angiotensin-activated signaling pathway involved in heart process(GO:0086098) |
3.3 | 6.6 | GO:0090427 | activation of meiosis(GO:0090427) |
3.3 | 23.2 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
3.3 | 19.8 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
3.3 | 16.5 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
3.3 | 29.6 | GO:0071625 | vocalization behavior(GO:0071625) |
3.3 | 26.2 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
3.2 | 188.4 | GO:1901379 | regulation of potassium ion transmembrane transport(GO:1901379) |
3.2 | 19.5 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
3.2 | 13.0 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
3.2 | 9.7 | GO:0003245 | cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
3.2 | 16.2 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
3.2 | 12.9 | GO:0035524 | proline transmembrane transport(GO:0035524) |
3.2 | 9.6 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
3.2 | 9.6 | GO:0003365 | establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
3.2 | 9.6 | GO:0010615 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
3.2 | 12.8 | GO:0003360 | brainstem development(GO:0003360) |
3.2 | 16.0 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
3.2 | 12.8 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
3.2 | 9.5 | GO:0030974 | thiamine pyrophosphate transport(GO:0030974) |
3.2 | 31.8 | GO:0032288 | myelin assembly(GO:0032288) |
3.2 | 3.2 | GO:0072368 | regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter(GO:0072368) |
3.2 | 25.4 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
3.2 | 60.3 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
3.2 | 38.1 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
3.2 | 9.5 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
3.2 | 3.2 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
3.2 | 3.2 | GO:1904170 | regulation of bleb assembly(GO:1904170) positive regulation of bleb assembly(GO:1904172) |
3.2 | 6.3 | GO:0052564 | response to immune response of other organism involved in symbiotic interaction(GO:0052564) response to host immune response(GO:0052572) |
3.2 | 34.7 | GO:0051932 | synaptic transmission, GABAergic(GO:0051932) |
3.2 | 3.2 | GO:0032346 | positive regulation of aldosterone metabolic process(GO:0032346) positive regulation of aldosterone biosynthetic process(GO:0032349) |
3.2 | 44.1 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
3.1 | 75.5 | GO:0007616 | long-term memory(GO:0007616) |
3.1 | 9.4 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
3.1 | 22.0 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
3.1 | 12.5 | GO:0035617 | stress granule disassembly(GO:0035617) |
3.1 | 34.3 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
3.1 | 9.3 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
3.1 | 3.1 | GO:1990859 | cellular response to endothelin(GO:1990859) |
3.1 | 9.2 | GO:0060618 | nipple development(GO:0060618) |
3.1 | 9.2 | GO:0050932 | regulation of melanocyte differentiation(GO:0045634) regulation of pigment cell differentiation(GO:0050932) |
3.1 | 3.1 | GO:0046100 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
3.1 | 45.8 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
3.0 | 12.2 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
3.0 | 18.2 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
3.0 | 30.1 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
3.0 | 36.1 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
3.0 | 3.0 | GO:0010579 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
3.0 | 21.0 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
3.0 | 8.9 | GO:0002090 | regulation of receptor internalization(GO:0002090) |
3.0 | 44.3 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
3.0 | 17.7 | GO:0070294 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
2.9 | 11.8 | GO:0035989 | tendon development(GO:0035989) |
2.9 | 2.9 | GO:0097350 | neutrophil clearance(GO:0097350) |
2.9 | 79.4 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
2.9 | 2.9 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
2.9 | 8.8 | GO:0030961 | peptidyl-arginine hydroxylation(GO:0030961) |
2.9 | 135.0 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
2.9 | 44.0 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
2.9 | 26.4 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
2.9 | 5.8 | GO:0003032 | detection of oxygen(GO:0003032) |
2.9 | 37.7 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
2.9 | 20.3 | GO:0097501 | stress response to metal ion(GO:0097501) |
2.9 | 40.4 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
2.9 | 8.6 | GO:0042756 | drinking behavior(GO:0042756) |
2.9 | 14.4 | GO:0001550 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
2.9 | 20.0 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
2.9 | 20.0 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
2.9 | 2.9 | GO:0071469 | cellular response to alkaline pH(GO:0071469) |
2.8 | 34.1 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
2.8 | 82.5 | GO:0007269 | neurotransmitter secretion(GO:0007269) signal release from synapse(GO:0099643) |
2.8 | 2.8 | GO:0002276 | basophil activation involved in immune response(GO:0002276) |
2.8 | 19.9 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
2.8 | 28.3 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
2.8 | 11.3 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
2.8 | 8.5 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
2.8 | 25.4 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
2.8 | 31.0 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
2.8 | 16.7 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
2.8 | 2.8 | GO:2000977 | regulation of forebrain neuron differentiation(GO:2000977) |
2.8 | 74.8 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
2.8 | 8.3 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
2.8 | 11.0 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
2.8 | 5.5 | GO:2000650 | negative regulation of sodium ion transmembrane transporter activity(GO:2000650) |
2.7 | 40.9 | GO:0036065 | fucosylation(GO:0036065) |
2.7 | 2.7 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
2.7 | 59.9 | GO:0016486 | peptide hormone processing(GO:0016486) |
2.7 | 2.7 | GO:0051589 | negative regulation of neurotransmitter transport(GO:0051589) |
2.7 | 13.5 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
2.7 | 26.7 | GO:0007021 | tubulin complex assembly(GO:0007021) |
2.7 | 5.3 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
2.7 | 18.7 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
2.7 | 63.9 | GO:0060291 | long-term synaptic potentiation(GO:0060291) |
2.7 | 34.6 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
2.7 | 24.0 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
2.7 | 5.3 | GO:0097017 | renal protein absorption(GO:0097017) |
2.7 | 21.3 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
2.6 | 2.6 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
2.6 | 7.9 | GO:0033577 | protein glycosylation in endoplasmic reticulum(GO:0033577) |
2.6 | 7.9 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
2.6 | 7.9 | GO:0046462 | monoacylglycerol metabolic process(GO:0046462) |
2.6 | 57.8 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
2.6 | 18.3 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
2.6 | 23.6 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
2.6 | 7.8 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
2.6 | 23.5 | GO:2001046 | positive regulation of integrin-mediated signaling pathway(GO:2001046) |
2.6 | 10.4 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
2.6 | 7.8 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
2.6 | 13.0 | GO:0036006 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
2.6 | 15.6 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
2.6 | 5.2 | GO:1902959 | regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902959) positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) regulation of aspartic-type peptidase activity(GO:1905245) positive regulation of aspartic-type peptidase activity(GO:1905247) |
2.6 | 31.2 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
2.6 | 46.8 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
2.6 | 2.6 | GO:0015827 | aromatic amino acid transport(GO:0015801) tryptophan transport(GO:0015827) |
2.6 | 7.7 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
2.6 | 7.7 | GO:0015705 | iodide transport(GO:0015705) |
2.6 | 15.4 | GO:0006735 | NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
2.6 | 38.4 | GO:2001197 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
2.6 | 2.6 | GO:0072425 | signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
2.5 | 12.7 | GO:0098703 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
2.5 | 35.6 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
2.5 | 5.1 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
2.5 | 7.6 | GO:0030860 | regulation of polarized epithelial cell differentiation(GO:0030860) |
2.5 | 12.6 | GO:1903445 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
2.5 | 5.0 | GO:0061743 | motor learning(GO:0061743) |
2.5 | 5.0 | GO:0048069 | eye pigmentation(GO:0048069) |
2.5 | 15.1 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
2.5 | 90.1 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
2.5 | 17.5 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
2.5 | 12.5 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
2.5 | 7.5 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
2.5 | 17.4 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
2.5 | 7.5 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
2.5 | 2.5 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
2.5 | 74.4 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
2.5 | 76.7 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
2.5 | 41.7 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
2.5 | 2.5 | GO:0060825 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
2.4 | 22.0 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
2.4 | 4.9 | GO:0015824 | proline transport(GO:0015824) |
2.4 | 19.6 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
2.4 | 4.9 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) regulation of Cdc42 protein signal transduction(GO:0032489) |
2.4 | 4.9 | GO:0099526 | presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
2.4 | 31.6 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
2.4 | 9.7 | GO:0001964 | startle response(GO:0001964) |
2.4 | 9.7 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
2.4 | 9.7 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
2.4 | 17.0 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
2.4 | 7.3 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
2.4 | 50.8 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
2.4 | 31.2 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
2.4 | 31.1 | GO:0097033 | mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
2.4 | 7.2 | GO:0007439 | ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
2.4 | 11.9 | GO:0015888 | thiamine transport(GO:0015888) |
2.4 | 28.5 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
2.4 | 7.1 | GO:0071929 | alpha-tubulin acetylation(GO:0071929) |
2.4 | 16.6 | GO:0072092 | ureteric bud invasion(GO:0072092) |
2.4 | 26.0 | GO:0018095 | protein polyglutamylation(GO:0018095) |
2.4 | 14.2 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
2.4 | 9.4 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
2.4 | 18.9 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
2.4 | 11.8 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
2.4 | 2.4 | GO:0042275 | error-free postreplication DNA repair(GO:0042275) |
2.4 | 9.4 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
2.3 | 2.3 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
2.3 | 2.3 | GO:0032053 | ciliary basal body organization(GO:0032053) |
2.3 | 4.7 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
2.3 | 9.3 | GO:0032468 | cellular manganese ion homeostasis(GO:0030026) Golgi calcium ion homeostasis(GO:0032468) manganese ion homeostasis(GO:0055071) |
2.3 | 39.4 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
2.3 | 11.6 | GO:0006116 | NADH oxidation(GO:0006116) |
2.3 | 18.5 | GO:1904220 | regulation of serine C-palmitoyltransferase activity(GO:1904220) |
2.3 | 9.2 | GO:0071440 | regulation of histone H3-K14 acetylation(GO:0071440) |
2.3 | 9.2 | GO:0038016 | insulin receptor internalization(GO:0038016) |
2.3 | 27.6 | GO:0071971 | extracellular exosome assembly(GO:0071971) |
2.3 | 9.2 | GO:0050973 | detection of mechanical stimulus involved in equilibrioception(GO:0050973) |
2.3 | 6.9 | GO:0002931 | response to ischemia(GO:0002931) |
2.3 | 11.4 | GO:0002803 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antibacterial peptide production(GO:0002803) |
2.3 | 9.1 | GO:0072047 | proximal/distal pattern formation involved in nephron development(GO:0072047) specification of nephron tubule identity(GO:0072081) |
2.3 | 25.0 | GO:0072584 | caveolin-mediated endocytosis(GO:0072584) |
2.3 | 4.5 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
2.3 | 6.8 | GO:0015965 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
2.3 | 9.1 | GO:0045338 | farnesyl diphosphate metabolic process(GO:0045338) |
2.3 | 6.8 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
2.3 | 18.0 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
2.2 | 4.5 | GO:1903564 | regulation of protein localization to cilium(GO:1903564) |
2.2 | 2.2 | GO:0021825 | substrate-dependent cerebral cortex tangential migration(GO:0021825) |
2.2 | 2.2 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
2.2 | 4.5 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
2.2 | 4.5 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
2.2 | 4.5 | GO:0072034 | renal vesicle induction(GO:0072034) |
2.2 | 6.7 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
2.2 | 4.4 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
2.2 | 11.1 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
2.2 | 8.8 | GO:0051182 | coenzyme transport(GO:0051182) |
2.2 | 4.4 | GO:2000825 | positive regulation of androgen receptor activity(GO:2000825) |
2.2 | 13.2 | GO:1900118 | negative regulation of execution phase of apoptosis(GO:1900118) |
2.2 | 2.2 | GO:0002076 | osteoblast development(GO:0002076) |
2.2 | 35.1 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
2.2 | 2.2 | GO:0010446 | response to alkaline pH(GO:0010446) |
2.2 | 24.1 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
2.2 | 11.0 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
2.2 | 4.4 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
2.2 | 17.5 | GO:0014850 | response to muscle activity(GO:0014850) |
2.2 | 19.6 | GO:0006449 | regulation of translational termination(GO:0006449) |
2.2 | 2.2 | GO:0033189 | response to vitamin A(GO:0033189) |
2.2 | 6.5 | GO:0016598 | protein arginylation(GO:0016598) |
2.2 | 52.3 | GO:0008347 | glial cell migration(GO:0008347) |
2.2 | 8.7 | GO:0080163 | regulation of protein serine/threonine phosphatase activity(GO:0080163) |
2.2 | 65.1 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
2.2 | 21.7 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
2.2 | 6.5 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
2.2 | 2.2 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
2.2 | 8.7 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
2.2 | 15.1 | GO:1903748 | negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
2.2 | 6.5 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
2.2 | 6.5 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
2.1 | 8.6 | GO:0090177 | establishment of planar polarity involved in neural tube closure(GO:0090177) |
2.1 | 12.9 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
2.1 | 2.1 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
2.1 | 122.3 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
2.1 | 21.4 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
2.1 | 30.0 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
2.1 | 12.9 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
2.1 | 152.0 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
2.1 | 2.1 | GO:2001170 | negative regulation of energy homeostasis(GO:2000506) negative regulation of ATP biosynthetic process(GO:2001170) |
2.1 | 6.4 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
2.1 | 14.9 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
2.1 | 4.3 | GO:0048239 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
2.1 | 6.4 | GO:0035973 | aggrephagy(GO:0035973) |
2.1 | 6.4 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
2.1 | 19.1 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
2.1 | 2.1 | GO:0001579 | medium-chain fatty acid transport(GO:0001579) |
2.1 | 33.7 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
2.1 | 8.4 | GO:0034436 | glycoprotein transport(GO:0034436) |
2.1 | 2.1 | GO:0044154 | histone H3-K14 acetylation(GO:0044154) |
2.1 | 2.1 | GO:1900025 | negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
2.1 | 10.5 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
2.1 | 16.8 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
2.1 | 8.3 | GO:0036060 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) |
2.1 | 4.2 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
2.1 | 8.3 | GO:1900368 | regulation of RNA interference(GO:1900368) |
2.1 | 31.2 | GO:0015813 | L-glutamate transport(GO:0015813) |
2.1 | 8.3 | GO:0000390 | spliceosomal complex disassembly(GO:0000390) |
2.1 | 31.2 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
2.1 | 4.2 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
2.1 | 4.2 | GO:0002842 | positive regulation of T cell mediated immune response to tumor cell(GO:0002842) |
2.1 | 6.2 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
2.1 | 10.4 | GO:2000437 | regulation of monocyte extravasation(GO:2000437) |
2.1 | 2.1 | GO:1903527 | regulation of membrane tubulation(GO:1903525) positive regulation of membrane tubulation(GO:1903527) |
2.1 | 16.6 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
2.1 | 72.4 | GO:0022011 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
2.1 | 20.7 | GO:0097061 | dendritic spine organization(GO:0097061) |
2.1 | 64.1 | GO:0045761 | regulation of adenylate cyclase activity(GO:0045761) |
2.1 | 6.2 | GO:2000987 | positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
2.1 | 12.4 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
2.1 | 6.2 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
2.0 | 49.2 | GO:0042118 | endothelial cell activation(GO:0042118) |
2.0 | 26.6 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
2.0 | 2.0 | GO:0099563 | modification of synaptic structure(GO:0099563) |
2.0 | 2.0 | GO:0032252 | secretory granule localization(GO:0032252) |
2.0 | 30.6 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
2.0 | 71.3 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
2.0 | 10.2 | GO:0022615 | protein to membrane docking(GO:0022615) |
2.0 | 6.1 | GO:0031642 | negative regulation of myelination(GO:0031642) |
2.0 | 2.0 | GO:0015800 | acidic amino acid transport(GO:0015800) |
2.0 | 6.1 | GO:1903061 | regulation of protein lipidation(GO:1903059) positive regulation of protein lipidation(GO:1903061) |
2.0 | 18.1 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
2.0 | 12.0 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
2.0 | 11.9 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
2.0 | 43.3 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
2.0 | 113.6 | GO:0007416 | synapse assembly(GO:0007416) |
2.0 | 5.9 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
1.9 | 3.9 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
1.9 | 5.8 | GO:0090170 | regulation of Golgi inheritance(GO:0090170) |
1.9 | 137.9 | GO:0050770 | regulation of axonogenesis(GO:0050770) |
1.9 | 9.7 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
1.9 | 46.4 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
1.9 | 1.9 | GO:0030431 | sleep(GO:0030431) |
1.9 | 1.9 | GO:0021840 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
1.9 | 5.8 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
1.9 | 11.5 | GO:0035902 | response to immobilization stress(GO:0035902) |
1.9 | 19.1 | GO:0032264 | IMP salvage(GO:0032264) |
1.9 | 5.7 | GO:1904924 | negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
1.9 | 9.5 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
1.9 | 1.9 | GO:0048143 | astrocyte activation(GO:0048143) |
1.9 | 3.8 | GO:2001160 | regulation of histone H3-K79 methylation(GO:2001160) |
1.9 | 3.8 | GO:0038109 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
1.9 | 11.3 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
1.9 | 1.9 | GO:0042069 | regulation of catecholamine metabolic process(GO:0042069) |
1.9 | 13.2 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
1.9 | 1.9 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
1.9 | 1.9 | GO:0014045 | establishment of endothelial blood-brain barrier(GO:0014045) |
1.9 | 1.9 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
1.9 | 1.9 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
1.9 | 37.4 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
1.9 | 26.2 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
1.9 | 1.9 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
1.9 | 72.7 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
1.9 | 1.9 | GO:0032439 | endosome localization(GO:0032439) |
1.9 | 3.7 | GO:0043589 | skin morphogenesis(GO:0043589) |
1.9 | 1.9 | GO:0003275 | apoptotic process involved in outflow tract morphogenesis(GO:0003275) regulation of apoptotic process involved in outflow tract morphogenesis(GO:1902256) |
1.9 | 11.1 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
1.8 | 14.8 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
1.8 | 31.4 | GO:0015693 | magnesium ion transport(GO:0015693) |
1.8 | 3.7 | GO:0090034 | regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
1.8 | 12.8 | GO:0051541 | elastin metabolic process(GO:0051541) |
1.8 | 5.5 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
1.8 | 7.3 | GO:0097167 | circadian regulation of translation(GO:0097167) |
1.8 | 1.8 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
1.8 | 16.4 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
1.8 | 5.4 | GO:1900477 | negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter(GO:1900477) |
1.8 | 7.2 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
1.8 | 10.9 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
1.8 | 14.4 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
1.8 | 9.0 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
1.8 | 5.4 | GO:0046491 | L-methylmalonyl-CoA metabolic process(GO:0046491) |
1.8 | 7.2 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
1.8 | 8.9 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
1.8 | 7.1 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
1.8 | 12.5 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
1.8 | 24.9 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
1.8 | 12.5 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
1.8 | 44.4 | GO:0009214 | cyclic nucleotide catabolic process(GO:0009214) |
1.8 | 3.6 | GO:0099638 | endosome to plasma membrane protein transport(GO:0099638) |
1.8 | 5.3 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
1.8 | 7.1 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
1.8 | 3.5 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
1.8 | 7.0 | GO:0034553 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
1.8 | 10.5 | GO:0035372 | protein localization to microtubule(GO:0035372) |
1.8 | 45.6 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
1.8 | 1.8 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
1.7 | 1.7 | GO:0071415 | cellular response to purine-containing compound(GO:0071415) |
1.7 | 3.5 | GO:0046098 | guanine metabolic process(GO:0046098) |
1.7 | 12.2 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
1.7 | 8.7 | GO:0072139 | glomerular parietal epithelial cell differentiation(GO:0072139) |
1.7 | 13.9 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
1.7 | 24.3 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
1.7 | 5.2 | GO:0060437 | lung growth(GO:0060437) |
1.7 | 5.2 | GO:0051030 | snRNA transport(GO:0051030) |
1.7 | 1.7 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
1.7 | 1.7 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) |
1.7 | 6.9 | GO:0030035 | microspike assembly(GO:0030035) |
1.7 | 22.2 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
1.7 | 11.9 | GO:0006561 | proline biosynthetic process(GO:0006561) |
1.7 | 5.1 | GO:0032224 | regulation of synaptic transmission, cholinergic(GO:0032222) positive regulation of synaptic transmission, cholinergic(GO:0032224) |
1.7 | 5.1 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
1.7 | 8.4 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
1.7 | 13.5 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
1.7 | 3.4 | GO:0060152 | peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
1.7 | 1.7 | GO:0001575 | globoside metabolic process(GO:0001575) |
1.7 | 3.3 | GO:0031959 | mineralocorticoid receptor signaling pathway(GO:0031959) |
1.7 | 3.3 | GO:0045792 | negative regulation of cell size(GO:0045792) |
1.7 | 13.3 | GO:0017185 | peptidyl-lysine hydroxylation(GO:0017185) |
1.7 | 14.9 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
1.7 | 9.9 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
1.7 | 3.3 | GO:0045906 | regulation of vascular smooth muscle contraction(GO:0003056) negative regulation of vasoconstriction(GO:0045906) negative regulation of vascular smooth muscle contraction(GO:1904694) |
1.7 | 5.0 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
1.6 | 6.6 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
1.6 | 1.6 | GO:1900034 | regulation of cellular response to heat(GO:1900034) |
1.6 | 14.7 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) |
1.6 | 34.0 | GO:0032456 | endocytic recycling(GO:0032456) |
1.6 | 43.6 | GO:0006743 | ubiquinone metabolic process(GO:0006743) |
1.6 | 12.9 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
1.6 | 37.0 | GO:0032411 | positive regulation of transporter activity(GO:0032411) |
1.6 | 3.2 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
1.6 | 4.8 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
1.6 | 3.2 | GO:0006677 | glycosylceramide metabolic process(GO:0006677) |
1.6 | 9.6 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
1.6 | 4.8 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
1.6 | 1.6 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
1.6 | 4.7 | GO:0044268 | multicellular organismal protein metabolic process(GO:0044268) |
1.6 | 15.8 | GO:0008088 | axo-dendritic transport(GO:0008088) |
1.6 | 6.3 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
1.6 | 15.8 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
1.6 | 4.7 | GO:0014889 | muscle atrophy(GO:0014889) |
1.6 | 84.9 | GO:0018149 | peptide cross-linking(GO:0018149) |
1.6 | 4.7 | GO:0002940 | tRNA N2-guanine methylation(GO:0002940) |
1.6 | 6.3 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
1.6 | 15.6 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
1.6 | 31.2 | GO:0070208 | protein heterotrimerization(GO:0070208) |
1.6 | 6.2 | GO:0048496 | maintenance of organ identity(GO:0048496) |
1.6 | 1.6 | GO:0021938 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
1.6 | 1.6 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
1.6 | 14.0 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
1.6 | 40.3 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
1.5 | 4.6 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
1.5 | 1.5 | GO:0021756 | striatum development(GO:0021756) |
1.5 | 16.9 | GO:0007215 | glutamate receptor signaling pathway(GO:0007215) |
1.5 | 1.5 | GO:0032328 | alanine transport(GO:0032328) |
1.5 | 18.5 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
1.5 | 16.9 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
1.5 | 6.1 | GO:1902044 | regulation of Fas signaling pathway(GO:1902044) negative regulation of Fas signaling pathway(GO:1902045) |
1.5 | 1.5 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
1.5 | 41.2 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
1.5 | 51.7 | GO:0051057 | positive regulation of small GTPase mediated signal transduction(GO:0051057) |
1.5 | 4.5 | GO:0048822 | enucleate erythrocyte development(GO:0048822) |
1.5 | 13.6 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
1.5 | 21.1 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
1.5 | 1.5 | GO:0072103 | renal system vasculature morphogenesis(GO:0061438) kidney vasculature morphogenesis(GO:0061439) glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
1.5 | 4.5 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
1.5 | 4.5 | GO:0030472 | mitotic spindle organization in nucleus(GO:0030472) |
1.5 | 7.4 | GO:0006983 | ER overload response(GO:0006983) |
1.5 | 4.5 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
1.5 | 1.5 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
1.5 | 4.4 | GO:0000349 | generation of catalytic spliceosome for first transesterification step(GO:0000349) |
1.5 | 31.0 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
1.5 | 14.8 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
1.5 | 2.9 | GO:0021762 | substantia nigra development(GO:0021762) |
1.5 | 2.9 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
1.5 | 5.9 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
1.5 | 4.4 | GO:0001806 | type IV hypersensitivity(GO:0001806) |
1.5 | 4.4 | GO:0009258 | 10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
1.4 | 8.7 | GO:2001205 | negative regulation of osteoclast development(GO:2001205) |
1.4 | 1.4 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
1.4 | 5.7 | GO:0043379 | memory T cell differentiation(GO:0043379) |
1.4 | 2.9 | GO:0090420 | naphthalene metabolic process(GO:0018931) naphthalene-containing compound metabolic process(GO:0090420) |
1.4 | 5.7 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
1.4 | 7.1 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
1.4 | 2.8 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
1.4 | 17.0 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
1.4 | 9.9 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
1.4 | 29.6 | GO:0097120 | receptor localization to synapse(GO:0097120) |
1.4 | 14.1 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
1.4 | 5.6 | GO:0015904 | tetracycline transport(GO:0015904) |
1.4 | 18.2 | GO:0090335 | regulation of brown fat cell differentiation(GO:0090335) |
1.4 | 15.3 | GO:0050806 | positive regulation of synaptic transmission(GO:0050806) |
1.4 | 5.5 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
1.4 | 4.1 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
1.4 | 5.5 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
1.4 | 11.0 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
1.4 | 6.8 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
1.4 | 24.6 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
1.4 | 6.8 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
1.4 | 5.4 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
1.4 | 2.7 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
1.4 | 2.7 | GO:2000836 | positive regulation of androgen secretion(GO:2000836) |
1.4 | 1.4 | GO:1904306 | positive regulation of gastro-intestinal system smooth muscle contraction(GO:1904306) |
1.3 | 2.7 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
1.3 | 14.8 | GO:0048278 | vesicle docking(GO:0048278) |
1.3 | 1.3 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
1.3 | 1.3 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
1.3 | 9.4 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
1.3 | 2.7 | GO:0046038 | GMP catabolic process(GO:0046038) |
1.3 | 25.4 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
1.3 | 64.1 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
1.3 | 5.3 | GO:0008050 | female courtship behavior(GO:0008050) |
1.3 | 2.7 | GO:0070831 | basement membrane assembly(GO:0070831) |
1.3 | 4.0 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
1.3 | 107.3 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
1.3 | 63.5 | GO:0048813 | dendrite morphogenesis(GO:0048813) |
1.3 | 1.3 | GO:0014829 | vascular smooth muscle contraction(GO:0014829) |
1.3 | 6.6 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
1.3 | 6.6 | GO:0038032 | termination of G-protein coupled receptor signaling pathway(GO:0038032) |
1.3 | 23.6 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
1.3 | 1.3 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
1.3 | 100.4 | GO:0010976 | positive regulation of neuron projection development(GO:0010976) |
1.3 | 1.3 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
1.3 | 31.2 | GO:0006991 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
1.3 | 1.3 | GO:1903056 | regulation of melanosome organization(GO:1903056) |
1.3 | 2.6 | GO:2000984 | regulation of ATP citrate synthase activity(GO:2000983) negative regulation of ATP citrate synthase activity(GO:2000984) |
1.3 | 2.6 | GO:0032474 | otolith morphogenesis(GO:0032474) |
1.3 | 14.1 | GO:0031643 | positive regulation of myelination(GO:0031643) |
1.3 | 35.5 | GO:0018345 | protein palmitoylation(GO:0018345) |
1.3 | 1.3 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
1.3 | 7.6 | GO:0034184 | positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
1.3 | 3.8 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
1.3 | 7.5 | GO:0099504 | synaptic vesicle cycle(GO:0099504) |
1.3 | 11.3 | GO:0015671 | oxygen transport(GO:0015671) |
1.3 | 5.0 | GO:0006563 | L-serine metabolic process(GO:0006563) |
1.2 | 9.9 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
1.2 | 8.6 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
1.2 | 4.9 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
1.2 | 6.1 | GO:0050807 | regulation of synapse organization(GO:0050807) |
1.2 | 1.2 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
1.2 | 3.6 | GO:0016131 | brassinosteroid metabolic process(GO:0016131) brassinosteroid biosynthetic process(GO:0016132) |
1.2 | 13.3 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
1.2 | 1.2 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
1.2 | 2.4 | GO:0010644 | cell communication by electrical coupling(GO:0010644) |
1.2 | 6.0 | GO:0035493 | SNARE complex assembly(GO:0035493) |
1.2 | 10.8 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
1.2 | 4.8 | GO:0015755 | fructose transport(GO:0015755) |
1.2 | 2.4 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
1.2 | 1.2 | GO:0021764 | amygdala development(GO:0021764) |
1.2 | 2.4 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
1.2 | 10.7 | GO:0043931 | ossification involved in bone maturation(GO:0043931) |
1.2 | 1.2 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
1.2 | 2.4 | GO:0000448 | cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000448) |
1.2 | 2.4 | GO:0002604 | dendritic cell antigen processing and presentation(GO:0002468) regulation of dendritic cell antigen processing and presentation(GO:0002604) positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
1.2 | 48.4 | GO:0050808 | synapse organization(GO:0050808) |
1.2 | 5.9 | GO:0072201 | negative regulation of mesenchymal cell proliferation(GO:0072201) |
1.2 | 5.9 | GO:0097309 | cap1 mRNA methylation(GO:0097309) |
1.2 | 9.4 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) |
1.2 | 4.7 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
1.2 | 76.7 | GO:0007612 | learning(GO:0007612) |
1.2 | 10.5 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
1.2 | 3.5 | GO:0098749 | cerebellar neuron development(GO:0098749) |
1.2 | 1.2 | GO:0098501 | polynucleotide dephosphorylation(GO:0098501) |
1.2 | 11.6 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
1.2 | 19.7 | GO:0090218 | positive regulation of lipid kinase activity(GO:0090218) |
1.2 | 8.1 | GO:0070314 | G1 to G0 transition(GO:0070314) |
1.2 | 3.5 | GO:2001107 | negative regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001107) |
1.2 | 2.3 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
1.1 | 21.8 | GO:0061462 | protein localization to lysosome(GO:0061462) |
1.1 | 5.7 | GO:0071233 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
1.1 | 2.3 | GO:0071318 | cellular response to ATP(GO:0071318) |
1.1 | 44.4 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
1.1 | 4.5 | GO:1902269 | positive regulation of polyamine transmembrane transport(GO:1902269) |
1.1 | 3.4 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
1.1 | 3.4 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
1.1 | 3.4 | GO:0032218 | riboflavin transport(GO:0032218) |
1.1 | 11.2 | GO:0048251 | elastic fiber assembly(GO:0048251) |
1.1 | 9.0 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
1.1 | 7.8 | GO:0016322 | neuron remodeling(GO:0016322) |
1.1 | 4.5 | GO:1904428 | negative regulation of tubulin deacetylation(GO:1904428) |
1.1 | 4.5 | GO:1904953 | Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904953) |
1.1 | 8.9 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
1.1 | 8.9 | GO:0033227 | dsRNA transport(GO:0033227) |
1.1 | 2.2 | GO:0019858 | cytosine metabolic process(GO:0019858) |
1.1 | 1.1 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
1.1 | 3.3 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
1.1 | 2.2 | GO:0033605 | positive regulation of catecholamine secretion(GO:0033605) |
1.1 | 6.5 | GO:0021799 | cerebral cortex radially oriented cell migration(GO:0021799) |
1.1 | 4.4 | GO:0032056 | positive regulation of translation in response to stress(GO:0032056) |
1.1 | 2.2 | GO:0040009 | regulation of growth rate(GO:0040009) |
1.1 | 7.5 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
1.1 | 3.2 | GO:0006624 | vacuolar protein processing(GO:0006624) |
1.1 | 19.4 | GO:0000338 | protein deneddylation(GO:0000338) |
1.1 | 15.0 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
1.1 | 3.2 | GO:0070625 | zymogen granule exocytosis(GO:0070625) |
1.1 | 5.3 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
1.1 | 6.4 | GO:0035063 | nuclear speck organization(GO:0035063) |
1.1 | 7.4 | GO:0006751 | glutathione catabolic process(GO:0006751) |
1.1 | 8.5 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
1.1 | 2.1 | GO:0048520 | positive regulation of behavior(GO:0048520) |
1.1 | 2.1 | GO:0006649 | phospholipid transfer to membrane(GO:0006649) |
1.1 | 4.2 | GO:0043418 | homocysteine catabolic process(GO:0043418) |
1.1 | 9.5 | GO:0050773 | regulation of dendrite development(GO:0050773) |
1.1 | 5.3 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
1.1 | 4.2 | GO:0050812 | regulation of acyl-CoA biosynthetic process(GO:0050812) |
1.0 | 1.0 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
1.0 | 4.2 | GO:1901026 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
1.0 | 6.3 | GO:0034331 | cell junction maintenance(GO:0034331) |
1.0 | 20.9 | GO:0007220 | Notch receptor processing(GO:0007220) |
1.0 | 6.3 | GO:0048675 | axon extension(GO:0048675) |
1.0 | 13.6 | GO:0048678 | response to axon injury(GO:0048678) |
1.0 | 4.1 | GO:0060807 | cardiogenic plate morphogenesis(GO:0003142) regulation of transcription from RNA polymerase II promoter involved in definitive endodermal cell fate specification(GO:0060807) regulation of cardiac cell fate specification(GO:2000043) |
1.0 | 3.1 | GO:0002380 | immunoglobulin secretion involved in immune response(GO:0002380) |
1.0 | 14.3 | GO:0051043 | regulation of membrane protein ectodomain proteolysis(GO:0051043) positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
1.0 | 24.5 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
1.0 | 2.0 | GO:0060715 | syncytiotrophoblast cell differentiation involved in labyrinthine layer development(GO:0060715) |
1.0 | 1.0 | GO:0016264 | gap junction assembly(GO:0016264) |
1.0 | 3.1 | GO:0042891 | antibiotic transport(GO:0042891) |
1.0 | 4.1 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
1.0 | 1.0 | GO:0021843 | substrate-independent telencephalic tangential migration(GO:0021826) substrate-independent telencephalic tangential interneuron migration(GO:0021843) |
1.0 | 3.0 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
1.0 | 1.0 | GO:0045013 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
1.0 | 1.0 | GO:0021508 | ventral midline development(GO:0007418) floor plate formation(GO:0021508) |
1.0 | 4.0 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
1.0 | 2.0 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
1.0 | 2.0 | GO:0060155 | platelet dense granule organization(GO:0060155) |
1.0 | 2.0 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
1.0 | 3.9 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
1.0 | 4.9 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
1.0 | 105.1 | GO:0007224 | smoothened signaling pathway(GO:0007224) |
1.0 | 1.0 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
1.0 | 12.7 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
1.0 | 9.8 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
1.0 | 2.9 | GO:0031990 | mRNA export from nucleus in response to heat stress(GO:0031990) |
1.0 | 2.0 | GO:0031268 | pseudopodium organization(GO:0031268) |
1.0 | 4.9 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
1.0 | 2.9 | GO:0070376 | regulation of ERK5 cascade(GO:0070376) |
1.0 | 7.8 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
1.0 | 5.8 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
1.0 | 4.8 | GO:1990138 | neuron projection extension(GO:1990138) |
1.0 | 9.6 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
1.0 | 1.9 | GO:0061591 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
1.0 | 3.8 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
1.0 | 10.6 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
1.0 | 2.9 | GO:0040010 | positive regulation of growth rate(GO:0040010) |
1.0 | 5.8 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
1.0 | 4.8 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
1.0 | 3.8 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.9 | 2.8 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.9 | 6.6 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.9 | 5.7 | GO:0080009 | mRNA methylation(GO:0080009) |
0.9 | 0.9 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.9 | 21.5 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.9 | 0.9 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.9 | 11.1 | GO:0010842 | retina layer formation(GO:0010842) |
0.9 | 15.8 | GO:0021766 | hippocampus development(GO:0021766) |
0.9 | 1.9 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.9 | 4.6 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.9 | 2.8 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.9 | 3.7 | GO:0018343 | protein farnesylation(GO:0018343) |
0.9 | 4.6 | GO:2001166 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
0.9 | 4.6 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.9 | 3.7 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.9 | 30.9 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.9 | 0.9 | GO:0060789 | hair follicle placode formation(GO:0060789) |
0.9 | 2.7 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
0.9 | 0.9 | GO:1904798 | regulation of core promoter binding(GO:1904796) positive regulation of core promoter binding(GO:1904798) |
0.9 | 0.9 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
0.9 | 0.9 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.9 | 0.9 | GO:0045794 | negative regulation of cell volume(GO:0045794) |
0.9 | 3.6 | GO:0060785 | regulation of apoptosis involved in tissue homeostasis(GO:0060785) |
0.9 | 13.4 | GO:0097034 | mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.9 | 0.9 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
0.9 | 8.0 | GO:0021696 | cerebellar cortex morphogenesis(GO:0021696) |
0.9 | 50.9 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
0.9 | 5.3 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.9 | 16.8 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.9 | 8.8 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.9 | 1.8 | GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) peptidyl-arginine omega-N-methylation(GO:0035247) |
0.9 | 3.5 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.9 | 7.0 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.9 | 2.6 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.9 | 5.3 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.9 | 74.4 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.9 | 28.8 | GO:0051693 | actin filament capping(GO:0051693) |
0.9 | 1.7 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.9 | 7.8 | GO:0044803 | multi-organism membrane organization(GO:0044803) |
0.9 | 10.5 | GO:0022410 | circadian sleep/wake cycle process(GO:0022410) |
0.9 | 1.7 | GO:0050712 | negative regulation of interleukin-1 alpha production(GO:0032690) regulation of interleukin-1 alpha secretion(GO:0050705) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
0.9 | 0.9 | GO:0044830 | modulation by host of viral RNA genome replication(GO:0044830) |
0.9 | 13.6 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.8 | 5.9 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.8 | 11.8 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.8 | 6.7 | GO:0031179 | peptide modification(GO:0031179) |
0.8 | 2.5 | GO:0072396 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
0.8 | 1.7 | GO:1902896 | terminal web assembly(GO:1902896) |
0.8 | 3.3 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.8 | 1.7 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.8 | 6.6 | GO:0046469 | platelet activating factor metabolic process(GO:0046469) |
0.8 | 4.9 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.8 | 1.6 | GO:0006409 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
0.8 | 6.5 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.8 | 3.2 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.8 | 0.8 | GO:2001279 | regulation of prostaglandin biosynthetic process(GO:0031392) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) |
0.8 | 26.5 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.8 | 1.6 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.8 | 1.6 | GO:0010908 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) |
0.8 | 1.6 | GO:0010424 | DNA methylation on cytosine within a CG sequence(GO:0010424) |
0.8 | 9.5 | GO:2000232 | regulation of rRNA processing(GO:2000232) |
0.8 | 13.4 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.8 | 2.4 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
0.8 | 0.8 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
0.8 | 8.6 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) |
0.8 | 3.1 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.8 | 5.4 | GO:0051958 | methotrexate transport(GO:0051958) |
0.8 | 2.3 | GO:0055011 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
0.8 | 3.8 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
0.8 | 10.0 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.8 | 0.8 | GO:0048263 | determination of dorsal/ventral asymmetry(GO:0048262) determination of dorsal identity(GO:0048263) |
0.8 | 0.8 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.8 | 32.1 | GO:0034605 | cellular response to heat(GO:0034605) |
0.8 | 9.1 | GO:0016559 | peroxisome fission(GO:0016559) |
0.8 | 7.6 | GO:0042982 | amyloid precursor protein metabolic process(GO:0042982) |
0.8 | 3.8 | GO:0009227 | nucleotide-sugar catabolic process(GO:0009227) |
0.8 | 2.3 | GO:0034476 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) |
0.8 | 11.4 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.8 | 3.0 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.8 | 0.8 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.8 | 21.0 | GO:0010761 | fibroblast migration(GO:0010761) |
0.8 | 6.0 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.8 | 5.3 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.7 | 3.0 | GO:1990481 | mRNA pseudouridine synthesis(GO:1990481) |
0.7 | 2.2 | GO:0043519 | myosin II filament organization(GO:0031038) regulation of myosin II filament organization(GO:0043519) |
0.7 | 3.7 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.7 | 7.5 | GO:0010771 | negative regulation of cell morphogenesis involved in differentiation(GO:0010771) |
0.7 | 0.7 | GO:1902730 | positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.7 | 17.9 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.7 | 21.5 | GO:0007200 | phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
0.7 | 3.0 | GO:0000105 | histidine biosynthetic process(GO:0000105) |
0.7 | 3.7 | GO:0042435 | indole-containing compound biosynthetic process(GO:0042435) |
0.7 | 2.2 | GO:0019389 | glucuronoside metabolic process(GO:0019389) |
0.7 | 5.8 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.7 | 8.7 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.7 | 2.2 | GO:0036079 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
0.7 | 1.4 | GO:0015867 | ATP transport(GO:0015867) |
0.7 | 8.6 | GO:0002093 | auditory receptor cell morphogenesis(GO:0002093) |
0.7 | 23.5 | GO:0007266 | Rho protein signal transduction(GO:0007266) |
0.7 | 2.8 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.7 | 2.1 | GO:1990258 | box C/D snoRNA 3'-end processing(GO:0000494) box C/D snoRNA metabolic process(GO:0033967) box C/D snoRNA processing(GO:0034963) histone glutamine methylation(GO:1990258) |
0.7 | 2.8 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.7 | 2.1 | GO:1990182 | exosomal secretion(GO:1990182) |
0.7 | 32.7 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.7 | 3.5 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
0.7 | 6.2 | GO:0071816 | tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.7 | 25.9 | GO:0007045 | cell-substrate adherens junction assembly(GO:0007045) focal adhesion assembly(GO:0048041) |
0.7 | 1.3 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.7 | 2.0 | GO:0071569 | protein ufmylation(GO:0071569) |
0.7 | 5.4 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.7 | 2.0 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.7 | 0.7 | GO:0034201 | response to oleic acid(GO:0034201) |
0.7 | 2.0 | GO:0006903 | vesicle targeting(GO:0006903) |
0.7 | 1.3 | GO:0090285 | negative regulation of protein glycosylation in Golgi(GO:0090285) |
0.7 | 2.0 | GO:0044376 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
0.7 | 11.3 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.7 | 0.7 | GO:0002692 | negative regulation of cellular extravasation(GO:0002692) |
0.7 | 8.6 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.7 | 2.0 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.7 | 11.8 | GO:0019228 | neuronal action potential(GO:0019228) |
0.7 | 4.6 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.7 | 2.6 | GO:0030091 | protein repair(GO:0030091) |
0.7 | 2.0 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.6 | 0.6 | GO:0061564 | axon development(GO:0061564) |
0.6 | 15.5 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.6 | 2.5 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.6 | 5.1 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.6 | 4.4 | GO:0061083 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.6 | 1.9 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.6 | 10.8 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.6 | 1.3 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.6 | 1.9 | GO:0010705 | meiotic DNA double-strand break processing involved in reciprocal meiotic recombination(GO:0010705) |
0.6 | 10.6 | GO:0007032 | endosome organization(GO:0007032) |
0.6 | 1.9 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
0.6 | 93.2 | GO:0048812 | neuron projection morphogenesis(GO:0048812) |
0.6 | 5.6 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.6 | 1.9 | GO:0000451 | rRNA 2'-O-methylation(GO:0000451) |
0.6 | 34.7 | GO:0051592 | response to calcium ion(GO:0051592) |
0.6 | 1.8 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.6 | 1.8 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
0.6 | 11.0 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.6 | 0.6 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.6 | 0.6 | GO:0035332 | positive regulation of hippo signaling(GO:0035332) |
0.6 | 3.0 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.6 | 3.0 | GO:2000002 | negative regulation of DNA damage checkpoint(GO:2000002) |
0.6 | 0.6 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.6 | 0.6 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.6 | 3.6 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.6 | 0.6 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.6 | 0.6 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.6 | 4.2 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.6 | 1.8 | GO:0021664 | rhombomere formation(GO:0021594) rhombomere 3 formation(GO:0021660) rhombomere 5 morphogenesis(GO:0021664) rhombomere 5 formation(GO:0021666) |
0.6 | 4.1 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.6 | 1.2 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.6 | 5.3 | GO:0046033 | AMP metabolic process(GO:0046033) |
0.6 | 5.3 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.6 | 8.8 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.6 | 0.6 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.6 | 2.3 | GO:0015919 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.6 | 48.4 | GO:0098916 | chemical synaptic transmission(GO:0007268) anterograde trans-synaptic signaling(GO:0098916) |
0.6 | 7.5 | GO:0015747 | urate transport(GO:0015747) |
0.6 | 1.7 | GO:1902164 | positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
0.6 | 1.1 | GO:0018312 | peptidyl-serine ADP-ribosylation(GO:0018312) |
0.6 | 4.0 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.6 | 2.3 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) inositol phosphate catabolic process(GO:0071545) |
0.6 | 1.7 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.6 | 31.9 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.6 | 0.6 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
0.6 | 11.7 | GO:0060749 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.6 | 1.7 | GO:0009107 | lipoate biosynthetic process(GO:0009107) |
0.6 | 0.6 | GO:0098780 | response to mitochondrial depolarisation(GO:0098780) |
0.6 | 16.1 | GO:0006821 | chloride transport(GO:0006821) |
0.6 | 2.8 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.6 | 1.7 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.6 | 0.6 | GO:0033634 | positive regulation of integrin activation(GO:0033625) positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.6 | 0.6 | GO:0051013 | microtubule severing(GO:0051013) |
0.5 | 0.5 | GO:0002759 | regulation of antimicrobial humoral response(GO:0002759) |
0.5 | 2.2 | GO:0070417 | cellular response to cold(GO:0070417) |
0.5 | 0.5 | GO:0045583 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.5 | 14.1 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.5 | 6.0 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.5 | 4.3 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.5 | 1.6 | GO:0015817 | histidine transport(GO:0015817) |
0.5 | 0.5 | GO:0061046 | regulation of branching involved in lung morphogenesis(GO:0061046) |
0.5 | 6.0 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.5 | 28.0 | GO:0001764 | neuron migration(GO:0001764) |
0.5 | 6.5 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.5 | 2.7 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) negative regulation of mitophagy(GO:1903147) |
0.5 | 1.1 | GO:0046984 | regulation of hemoglobin biosynthetic process(GO:0046984) |
0.5 | 1.1 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.5 | 0.5 | GO:0002248 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) |
0.5 | 12.1 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
0.5 | 2.1 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
0.5 | 1.0 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.5 | 2.6 | GO:0019695 | choline metabolic process(GO:0019695) |
0.5 | 0.5 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.5 | 8.8 | GO:0097576 | autophagosome maturation(GO:0097352) vacuole fusion(GO:0097576) |
0.5 | 3.1 | GO:0030242 | pexophagy(GO:0030242) |
0.5 | 35.2 | GO:0035308 | negative regulation of protein dephosphorylation(GO:0035308) |
0.5 | 10.1 | GO:0035773 | insulin secretion involved in cellular response to glucose stimulus(GO:0035773) |
0.5 | 1.5 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.5 | 1.5 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.5 | 3.0 | GO:0006085 | acetyl-CoA biosynthetic process(GO:0006085) |
0.5 | 1.0 | GO:0090365 | regulation of mRNA modification(GO:0090365) negative regulation of mRNA modification(GO:0090367) |
0.5 | 2.4 | GO:1900150 | regulation of defense response to fungus(GO:1900150) regulation of antifungal innate immune response(GO:1905034) negative regulation of antifungal innate immune response(GO:1905035) |
0.5 | 1.9 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.5 | 3.4 | GO:0042921 | corticosteroid receptor signaling pathway(GO:0031958) glucocorticoid receptor signaling pathway(GO:0042921) |
0.5 | 1.9 | GO:0042637 | catagen(GO:0042637) |
0.5 | 1.9 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.5 | 0.9 | GO:0036245 | cellular response to menadione(GO:0036245) |
0.5 | 0.5 | GO:0032308 | positive regulation of prostaglandin secretion(GO:0032308) |
0.5 | 9.9 | GO:0065002 | intracellular protein transmembrane transport(GO:0065002) protein transmembrane transport(GO:0071806) |
0.5 | 10.4 | GO:0051453 | regulation of intracellular pH(GO:0051453) |
0.5 | 7.1 | GO:0008593 | regulation of Notch signaling pathway(GO:0008593) |
0.5 | 1.4 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
0.5 | 1.9 | GO:0007525 | somatic muscle development(GO:0007525) |
0.5 | 0.9 | GO:0060857 | establishment of glial blood-brain barrier(GO:0060857) |
0.5 | 0.9 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.5 | 2.3 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.5 | 0.5 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.4 | 4.5 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.4 | 1.8 | GO:0018201 | peptidyl-glycine modification(GO:0018201) |
0.4 | 1.8 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.4 | 0.4 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.4 | 5.7 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.4 | 59.9 | GO:0019236 | response to pheromone(GO:0019236) |
0.4 | 0.9 | GO:0010877 | lipid transport involved in lipid storage(GO:0010877) |
0.4 | 3.9 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.4 | 1.3 | GO:0006175 | adenosine salvage(GO:0006169) dATP biosynthetic process(GO:0006175) |
0.4 | 0.4 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.4 | 1.3 | GO:0006780 | uroporphyrinogen III biosynthetic process(GO:0006780) |
0.4 | 3.4 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
0.4 | 1.3 | GO:1903093 | regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
0.4 | 1.7 | GO:0006710 | androgen catabolic process(GO:0006710) |
0.4 | 3.4 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.4 | 3.4 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.4 | 1.7 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.4 | 6.2 | GO:1904869 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
0.4 | 38.5 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
0.4 | 0.4 | GO:0090075 | relaxation of muscle(GO:0090075) |
0.4 | 1.2 | GO:1901679 | nucleotide transmembrane transport(GO:1901679) |
0.4 | 2.1 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.4 | 1.2 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.4 | 2.1 | GO:0032918 | polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
0.4 | 5.3 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.4 | 4.5 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.4 | 1.6 | GO:1901160 | primary amino compound metabolic process(GO:1901160) |
0.4 | 3.3 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
0.4 | 0.4 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.4 | 2.0 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.4 | 0.8 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.4 | 14.4 | GO:0042773 | ATP synthesis coupled electron transport(GO:0042773) |
0.4 | 1.6 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.4 | 2.8 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.4 | 3.6 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.4 | 2.0 | GO:0007296 | vitellogenesis(GO:0007296) |
0.4 | 3.1 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.4 | 1.6 | GO:0086091 | regulation of heart rate by cardiac conduction(GO:0086091) |
0.4 | 3.9 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.4 | 5.8 | GO:0000272 | polysaccharide catabolic process(GO:0000272) |
0.4 | 3.1 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.4 | 8.4 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.4 | 2.7 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.4 | 3.4 | GO:0032700 | negative regulation of interleukin-17 production(GO:0032700) |
0.4 | 0.8 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
0.4 | 1.1 | GO:0080120 | CAAX-box protein processing(GO:0071586) CAAX-box protein maturation(GO:0080120) |
0.4 | 0.4 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.4 | 3.7 | GO:0043312 | neutrophil degranulation(GO:0043312) |
0.4 | 1.5 | GO:0001516 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.4 | 0.7 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.4 | 1.1 | GO:0018003 | peptidyl-lysine N6-acetylation(GO:0018003) |
0.4 | 0.7 | GO:0007632 | visual behavior(GO:0007632) |
0.4 | 0.4 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.4 | 1.4 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
0.4 | 1.1 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.4 | 2.1 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.3 | 1.0 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.3 | 2.4 | GO:1903003 | positive regulation of protein deubiquitination(GO:1903003) |
0.3 | 0.3 | GO:2000008 | regulation of protein localization to cell surface(GO:2000008) |
0.3 | 1.4 | GO:1904751 | positive regulation of protein localization to nucleolus(GO:1904751) |
0.3 | 0.7 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
0.3 | 1.0 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.3 | 1.7 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.3 | 1.3 | GO:1902267 | polyamine transport(GO:0015846) polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
0.3 | 0.3 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.3 | 0.3 | GO:0051665 | membrane raft localization(GO:0051665) |
0.3 | 2.6 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.3 | 4.3 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.3 | 3.3 | GO:0014003 | oligodendrocyte development(GO:0014003) |
0.3 | 4.2 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
0.3 | 1.3 | GO:0061450 | trophoblast cell migration(GO:0061450) |
0.3 | 1.3 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.3 | 2.2 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.3 | 1.6 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.3 | 5.7 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
0.3 | 0.3 | GO:1900135 | regulation of renin secretion into blood stream(GO:1900133) positive regulation of renin secretion into blood stream(GO:1900135) |
0.3 | 19.5 | GO:0090090 | negative regulation of canonical Wnt signaling pathway(GO:0090090) |
0.3 | 1.9 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.3 | 0.6 | GO:0060967 | negative regulation of posttranscriptional gene silencing(GO:0060149) negative regulation of gene silencing by miRNA(GO:0060965) negative regulation of gene silencing by RNA(GO:0060967) |
0.3 | 2.5 | GO:0040023 | nuclear migration(GO:0007097) establishment of nucleus localization(GO:0040023) |
0.3 | 1.6 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.3 | 0.3 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.3 | 1.8 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.3 | 2.5 | GO:0036260 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.3 | 1.2 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.3 | 2.1 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.3 | 0.3 | GO:1903896 | positive regulation of IRE1-mediated unfolded protein response(GO:1903896) |
0.3 | 0.9 | GO:0036509 | trimming of terminal mannose on B branch(GO:0036509) |
0.3 | 6.5 | GO:0046785 | microtubule polymerization(GO:0046785) |
0.3 | 0.6 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.3 | 2.3 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.3 | 1.1 | GO:0006231 | dTMP biosynthetic process(GO:0006231) dTMP metabolic process(GO:0046073) |
0.3 | 2.8 | GO:0016358 | dendrite development(GO:0016358) |
0.3 | 3.9 | GO:0098840 | protein transport along microtubule(GO:0098840) |
0.3 | 2.8 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.3 | 2.8 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.3 | 1.4 | GO:0097461 | ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
0.3 | 1.1 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.3 | 0.8 | GO:0035425 | autocrine signaling(GO:0035425) |
0.3 | 0.8 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.3 | 1.6 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.3 | 1.6 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.3 | 0.8 | GO:0009249 | protein lipoylation(GO:0009249) |
0.3 | 0.8 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
0.3 | 0.5 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.3 | 10.5 | GO:0060828 | regulation of canonical Wnt signaling pathway(GO:0060828) |
0.3 | 1.0 | GO:1902415 | regulation of mRNA binding(GO:1902415) |
0.3 | 2.3 | GO:0015809 | arginine transport(GO:0015809) |
0.3 | 1.3 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.3 | 5.1 | GO:0031623 | receptor internalization(GO:0031623) |
0.3 | 41.8 | GO:0007264 | small GTPase mediated signal transduction(GO:0007264) |
0.3 | 1.5 | GO:0034214 | protein hexamerization(GO:0034214) |
0.2 | 5.2 | GO:0031110 | regulation of microtubule polymerization or depolymerization(GO:0031110) |
0.2 | 0.5 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.2 | 1.5 | GO:0006415 | translational termination(GO:0006415) |
0.2 | 3.9 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.2 | 0.5 | GO:0035588 | G-protein coupled purinergic receptor signaling pathway(GO:0035588) |
0.2 | 7.2 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.2 | 5.6 | GO:0061512 | protein localization to cilium(GO:0061512) |
0.2 | 1.3 | GO:0016266 | O-glycan processing(GO:0016266) |
0.2 | 1.3 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.2 | 0.2 | GO:0060956 | stem cell fate commitment(GO:0048865) stem cell fate specification(GO:0048866) endocardium formation(GO:0060214) endocardial cell differentiation(GO:0060956) |
0.2 | 0.9 | GO:0052204 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.2 | 1.3 | GO:0006621 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.2 | 1.3 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) |
0.2 | 0.2 | GO:0097384 | cellular lipid biosynthetic process(GO:0097384) |
0.2 | 0.2 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.2 | 2.1 | GO:0042407 | cristae formation(GO:0042407) |
0.2 | 2.2 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.2 | 1.8 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.2 | 1.0 | GO:1990441 | negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
0.2 | 0.2 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.2 | 0.4 | GO:2001293 | malonyl-CoA metabolic process(GO:2001293) |
0.2 | 2.3 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.2 | 0.4 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.2 | 1.9 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.2 | 0.4 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
0.2 | 0.4 | GO:0035627 | ceramide transport(GO:0035627) |
0.2 | 2.6 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.2 | 0.9 | GO:0071718 | sodium-independent icosanoid transport(GO:0071718) |
0.2 | 0.4 | GO:0097479 | synaptic vesicle localization(GO:0097479) |
0.2 | 0.2 | GO:0060474 | positive regulation of sperm motility involved in capacitation(GO:0060474) |
0.2 | 3.7 | GO:1902600 | hydrogen ion transmembrane transport(GO:1902600) |
0.2 | 1.0 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.2 | 0.7 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.2 | 0.9 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.2 | 0.5 | GO:0042128 | nitrate assimilation(GO:0042128) |
0.2 | 0.3 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.2 | 0.3 | GO:0019086 | late viral transcription(GO:0019086) |
0.2 | 0.6 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.1 | 0.1 | GO:0019377 | glycolipid catabolic process(GO:0019377) |
0.1 | 12.1 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.1 | 0.1 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.1 | 1.2 | GO:0019471 | 4-hydroxyproline metabolic process(GO:0019471) |
0.1 | 2.8 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.1 | 0.6 | GO:0036337 | Fas signaling pathway(GO:0036337) |
0.1 | 0.4 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
0.1 | 0.7 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.1 | 0.1 | GO:0060157 | urinary bladder development(GO:0060157) |
0.1 | 0.7 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.1 | 0.4 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.1 | 1.1 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.1 | 1.3 | GO:0046697 | decidualization(GO:0046697) |
0.1 | 0.5 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.1 | 0.4 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.1 | 0.4 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
0.1 | 0.1 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.1 | 0.1 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.1 | 0.5 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
0.1 | 0.1 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.1 | 0.1 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
0.1 | 11.2 | GO:0061025 | membrane fusion(GO:0061025) |
0.1 | 3.6 | GO:0006664 | glycolipid metabolic process(GO:0006664) |
0.1 | 0.3 | GO:0009138 | dUDP biosynthetic process(GO:0006227) dTDP biosynthetic process(GO:0006233) pyrimidine nucleoside diphosphate metabolic process(GO:0009138) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dTDP metabolic process(GO:0046072) dUDP metabolic process(GO:0046077) |
0.1 | 0.4 | GO:0036035 | osteoclast development(GO:0036035) |
0.1 | 1.7 | GO:0007405 | neuroblast proliferation(GO:0007405) |
0.1 | 0.5 | GO:0006684 | sphingomyelin metabolic process(GO:0006684) |
0.1 | 0.2 | GO:0052041 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
0.1 | 0.2 | GO:0002551 | mast cell chemotaxis(GO:0002551) |
0.1 | 0.8 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 25.4 | GO:0007186 | G-protein coupled receptor signaling pathway(GO:0007186) |
0.1 | 0.4 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
0.1 | 0.3 | GO:0042335 | cuticle development(GO:0042335) |
0.1 | 1.5 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.1 | 1.0 | GO:0006497 | protein lipidation(GO:0006497) |
0.1 | 0.2 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.1 | 3.0 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.1 | 0.4 | GO:0002934 | desmosome organization(GO:0002934) |
0.1 | 0.1 | GO:1902080 | regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) |
0.1 | 0.1 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.1 | 0.1 | GO:0046949 | fatty-acyl-CoA biosynthetic process(GO:0046949) |
0.1 | 0.4 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.1 | 0.3 | GO:0015858 | nucleoside transport(GO:0015858) |
0.0 | 0.1 | GO:1903895 | negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
0.0 | 0.7 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.0 | 0.9 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.0 | 0.1 | GO:0022601 | menstrual cycle phase(GO:0022601) |
0.0 | 47.5 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.0 | 0.4 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 0.1 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.0 | 0.1 | GO:0070986 | left/right axis specification(GO:0070986) |
0.0 | 0.6 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.0 | 0.0 | GO:0003166 | bundle of His development(GO:0003166) |
0.0 | 0.1 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.0 | 0.4 | GO:0007000 | nucleolus organization(GO:0007000) |
0.0 | 0.1 | GO:0006601 | creatine biosynthetic process(GO:0006601) |
0.0 | 0.0 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.0 | 0.0 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.0 | 0.1 | GO:0090234 | regulation of kinetochore assembly(GO:0090234) |
0.0 | 0.1 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
0.0 | 0.1 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.0 | 0.1 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.0 | 0.0 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
18.0 | 18.0 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
15.9 | 79.3 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
14.2 | 156.6 | GO:1990812 | growth cone filopodium(GO:1990812) |
13.8 | 165.3 | GO:0044327 | dendritic spine head(GO:0044327) |
13.7 | 68.4 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
13.5 | 40.4 | GO:0098830 | presynaptic endosome(GO:0098830) |
12.9 | 64.3 | GO:0044308 | axonal spine(GO:0044308) |
12.4 | 37.3 | GO:0044302 | dentate gyrus mossy fiber(GO:0044302) |
11.2 | 44.9 | GO:0099573 | glutamatergic postsynaptic density(GO:0099573) |
10.6 | 159.6 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
10.5 | 84.1 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
9.8 | 58.9 | GO:0044305 | calyx of Held(GO:0044305) |
9.6 | 38.3 | GO:1990769 | proximal neuron projection(GO:1990769) |
9.5 | 38.1 | GO:0014802 | terminal cisterna(GO:0014802) |
9.2 | 18.4 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
9.2 | 18.3 | GO:0044322 | Derlin-1 retrotranslocation complex(GO:0036513) endoplasmic reticulum quality control compartment(GO:0044322) |
9.0 | 224.5 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
9.0 | 62.8 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
9.0 | 26.9 | GO:1990031 | pinceau fiber(GO:1990031) |
8.9 | 44.5 | GO:0098831 | presynaptic active zone cytoplasmic component(GO:0098831) |
8.8 | 44.1 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
8.7 | 34.9 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
8.7 | 34.8 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
8.5 | 238.1 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
8.5 | 76.3 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
8.4 | 352.8 | GO:0048786 | presynaptic active zone(GO:0048786) |
8.3 | 33.3 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
8.3 | 124.6 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
8.3 | 41.4 | GO:0044301 | climbing fiber(GO:0044301) |
8.2 | 287.5 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
8.2 | 319.7 | GO:0032590 | dendrite membrane(GO:0032590) |
8.2 | 8.2 | GO:0019034 | viral replication complex(GO:0019034) |
7.9 | 63.4 | GO:0033269 | internode region of axon(GO:0033269) |
7.9 | 7.9 | GO:0034677 | integrin alpha7-beta1 complex(GO:0034677) |
7.6 | 68.3 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
7.4 | 29.7 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
7.3 | 21.9 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
7.2 | 64.7 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
7.1 | 42.5 | GO:1903440 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
7.1 | 56.6 | GO:0032279 | asymmetric synapse(GO:0032279) |
6.8 | 13.6 | GO:1990257 | piccolo-bassoon transport vesicle(GO:1990257) |
6.7 | 66.7 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
6.7 | 146.8 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
6.6 | 86.1 | GO:0098845 | postsynaptic endosome(GO:0098845) |
6.4 | 25.5 | GO:0097444 | spine apparatus(GO:0097444) |
6.4 | 6.4 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
6.3 | 31.6 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
6.3 | 88.4 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
6.3 | 125.4 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
6.2 | 18.7 | GO:0098984 | neuron to neuron synapse(GO:0098984) |
6.0 | 102.2 | GO:0033270 | paranode region of axon(GO:0033270) |
5.9 | 237.7 | GO:0043194 | axon initial segment(GO:0043194) |
5.8 | 23.4 | GO:0072534 | perineuronal net(GO:0072534) |
5.8 | 52.4 | GO:0005883 | neurofilament(GO:0005883) |
5.6 | 50.5 | GO:0043083 | synaptic cleft(GO:0043083) |
5.6 | 16.7 | GO:1904602 | serotonin-activated cation-selective channel complex(GO:1904602) |
5.5 | 38.7 | GO:0097513 | myosin II filament(GO:0097513) |
5.5 | 27.6 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
5.4 | 69.9 | GO:0033268 | node of Ranvier(GO:0033268) |
5.2 | 446.4 | GO:0043198 | dendritic shaft(GO:0043198) |
5.2 | 10.4 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
5.2 | 15.5 | GO:1902912 | pyruvate kinase complex(GO:1902912) |
5.1 | 15.4 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
5.1 | 45.8 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
5.1 | 15.2 | GO:0016939 | kinesin II complex(GO:0016939) |
5.1 | 517.1 | GO:0034705 | potassium channel complex(GO:0034705) |
5.0 | 60.6 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
5.0 | 85.5 | GO:0031045 | dense core granule(GO:0031045) |
5.0 | 5.0 | GO:0005787 | signal peptidase complex(GO:0005787) |
4.9 | 14.8 | GO:0048179 | activin receptor complex(GO:0048179) |
4.9 | 29.6 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
4.9 | 24.5 | GO:1990745 | EARP complex(GO:1990745) |
4.8 | 250.0 | GO:0042734 | presynaptic membrane(GO:0042734) |
4.8 | 19.1 | GO:0042642 | actomyosin, myosin complex part(GO:0042642) |
4.7 | 14.2 | GO:0060205 | secretory granule lumen(GO:0034774) cytoplasmic membrane-bounded vesicle lumen(GO:0060205) |
4.7 | 14.0 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
4.6 | 9.2 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
4.6 | 27.5 | GO:0008091 | spectrin(GO:0008091) |
4.6 | 68.4 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
4.5 | 67.8 | GO:0031209 | SCAR complex(GO:0031209) |
4.5 | 379.4 | GO:0043195 | terminal bouton(GO:0043195) |
4.3 | 21.6 | GO:0035976 | AP1 complex(GO:0035976) |
4.3 | 12.8 | GO:0031904 | endosome lumen(GO:0031904) |
4.2 | 16.9 | GO:0071920 | cleavage body(GO:0071920) |
4.2 | 29.2 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
4.2 | 12.5 | GO:1990879 | CST complex(GO:1990879) |
4.1 | 61.4 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
4.1 | 36.7 | GO:0097427 | microtubule bundle(GO:0097427) |
4.1 | 12.2 | GO:0097635 | extrinsic component of autophagosome membrane(GO:0097635) |
4.0 | 4.0 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
4.0 | 225.0 | GO:0043679 | axon terminus(GO:0043679) |
3.8 | 88.5 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
3.8 | 61.4 | GO:0097449 | astrocyte projection(GO:0097449) |
3.8 | 26.9 | GO:0005955 | calcineurin complex(GO:0005955) |
3.8 | 57.0 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
3.8 | 3.8 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
3.8 | 22.8 | GO:0097443 | sorting endosome(GO:0097443) |
3.7 | 48.5 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
3.7 | 1199.8 | GO:0014069 | postsynaptic density(GO:0014069) |
3.7 | 3.7 | GO:0030690 | Noc1p-Noc2p complex(GO:0030690) |
3.6 | 7.3 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
3.6 | 18.1 | GO:1990130 | Iml1 complex(GO:1990130) |
3.6 | 21.7 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
3.5 | 56.5 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
3.5 | 10.6 | GO:1902560 | GMP reductase complex(GO:1902560) |
3.5 | 517.0 | GO:0098793 | presynapse(GO:0098793) |
3.5 | 42.1 | GO:0043203 | axon hillock(GO:0043203) |
3.5 | 38.3 | GO:0005818 | astral microtubule(GO:0000235) aster(GO:0005818) |
3.4 | 54.7 | GO:0016600 | flotillin complex(GO:0016600) |
3.4 | 105.9 | GO:0044295 | axonal growth cone(GO:0044295) |
3.4 | 20.5 | GO:0070382 | exocytic vesicle(GO:0070382) |
3.4 | 20.5 | GO:0016342 | catenin complex(GO:0016342) |
3.4 | 3.4 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
3.4 | 63.9 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
3.3 | 9.8 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
3.3 | 9.8 | GO:0036501 | UFD1-NPL4 complex(GO:0036501) |
3.3 | 84.6 | GO:0005922 | connexon complex(GO:0005922) |
3.2 | 708.4 | GO:0043209 | myelin sheath(GO:0043209) |
3.2 | 41.5 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
3.2 | 9.6 | GO:0070985 | TFIIK complex(GO:0070985) |
3.2 | 3.2 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
3.2 | 3.2 | GO:0030478 | actin cap(GO:0030478) |
3.1 | 182.4 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
3.1 | 21.4 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
3.0 | 21.1 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
3.0 | 39.0 | GO:0034464 | BBSome(GO:0034464) |
3.0 | 35.5 | GO:0045180 | basal cortex(GO:0045180) |
3.0 | 23.6 | GO:0032584 | growth cone membrane(GO:0032584) |
2.9 | 14.7 | GO:0036449 | microtubule minus-end(GO:0036449) |
2.9 | 32.3 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
2.9 | 26.0 | GO:0030314 | junctional membrane complex(GO:0030314) |
2.8 | 73.5 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
2.8 | 64.7 | GO:0060076 | excitatory synapse(GO:0060076) |
2.8 | 5.6 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
2.8 | 41.7 | GO:0035253 | ciliary rootlet(GO:0035253) |
2.8 | 16.6 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
2.8 | 72.1 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
2.8 | 8.3 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
2.7 | 13.6 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
2.7 | 48.5 | GO:0097440 | apical dendrite(GO:0097440) |
2.7 | 5.4 | GO:1990909 | Wnt signalosome(GO:1990909) |
2.7 | 10.8 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
2.7 | 16.1 | GO:0016328 | lateral plasma membrane(GO:0016328) |
2.6 | 372.4 | GO:0045211 | postsynaptic membrane(GO:0045211) |
2.6 | 68.1 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
2.6 | 18.3 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
2.6 | 23.5 | GO:0005801 | cis-Golgi network(GO:0005801) |
2.6 | 26.1 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
2.6 | 10.4 | GO:0002141 | stereocilia ankle link(GO:0002141) |
2.6 | 44.0 | GO:0042599 | lamellar body(GO:0042599) |
2.6 | 139.8 | GO:0005905 | clathrin-coated pit(GO:0005905) |
2.6 | 12.8 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
2.5 | 27.9 | GO:0031931 | TORC1 complex(GO:0031931) |
2.5 | 10.1 | GO:0005594 | collagen type IX trimer(GO:0005594) |
2.5 | 174.4 | GO:0043197 | dendritic spine(GO:0043197) neuron spine(GO:0044309) |
2.5 | 10.1 | GO:0060170 | ciliary membrane(GO:0060170) |
2.5 | 17.4 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
2.4 | 73.3 | GO:0071565 | nBAF complex(GO:0071565) |
2.4 | 7.3 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
2.4 | 4.8 | GO:0043202 | lysosomal lumen(GO:0043202) |
2.4 | 26.5 | GO:0016272 | prefoldin complex(GO:0016272) |
2.4 | 57.1 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
2.4 | 4.7 | GO:0034684 | integrin alphav-beta5 complex(GO:0034684) |
2.3 | 2.3 | GO:0097386 | glial cell projection(GO:0097386) |
2.3 | 130.1 | GO:0001533 | cornified envelope(GO:0001533) |
2.3 | 13.7 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
2.3 | 38.4 | GO:0036038 | MKS complex(GO:0036038) |
2.3 | 20.3 | GO:1904115 | axon cytoplasm(GO:1904115) |
2.2 | 9.0 | GO:0071797 | LUBAC complex(GO:0071797) |
2.2 | 68.8 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
2.2 | 6.7 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
2.2 | 4.4 | GO:0044393 | microspike(GO:0044393) |
2.2 | 46.1 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
2.1 | 23.3 | GO:0071437 | invadopodium(GO:0071437) |
2.1 | 2.1 | GO:0098574 | cytoplasmic side of lysosomal membrane(GO:0098574) |
2.1 | 6.2 | GO:1902636 | kinociliary basal body(GO:1902636) |
2.0 | 10.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
2.0 | 16.1 | GO:0071986 | Ragulator complex(GO:0071986) |
2.0 | 18.1 | GO:0071203 | WASH complex(GO:0071203) |
2.0 | 6.0 | GO:0034456 | CURI complex(GO:0032545) UTP-C complex(GO:0034456) |
2.0 | 25.5 | GO:0030673 | axolemma(GO:0030673) |
2.0 | 43.0 | GO:0030008 | TRAPP complex(GO:0030008) |
1.9 | 27.2 | GO:0030126 | COPI vesicle coat(GO:0030126) |
1.9 | 27.1 | GO:0005869 | dynactin complex(GO:0005869) |
1.9 | 9.7 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
1.9 | 5.8 | GO:0043512 | inhibin A complex(GO:0043512) |
1.9 | 1.9 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
1.9 | 11.5 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
1.9 | 3.8 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
1.9 | 1.9 | GO:0005607 | laminin-2 complex(GO:0005607) |
1.9 | 5.7 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
1.9 | 17.0 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
1.9 | 7.5 | GO:0042583 | chromaffin granule(GO:0042583) |
1.9 | 5.7 | GO:0016014 | dystrobrevin complex(GO:0016014) |
1.9 | 26.2 | GO:0005921 | gap junction(GO:0005921) |
1.9 | 22.4 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
1.9 | 111.0 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
1.8 | 5.5 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
1.8 | 171.9 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
1.8 | 7.3 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
1.8 | 3.6 | GO:0032437 | cuticular plate(GO:0032437) |
1.8 | 34.5 | GO:0005861 | troponin complex(GO:0005861) |
1.8 | 21.7 | GO:0031143 | pseudopodium(GO:0031143) |
1.8 | 41.0 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
1.8 | 8.8 | GO:0034271 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
1.7 | 22.7 | GO:0055038 | recycling endosome membrane(GO:0055038) |
1.7 | 12.2 | GO:0070695 | FHF complex(GO:0070695) |
1.7 | 7.0 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
1.7 | 3.5 | GO:0044753 | amphisome(GO:0044753) |
1.7 | 8.7 | GO:0071914 | prominosome(GO:0071914) |
1.7 | 5.2 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
1.7 | 15.5 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
1.7 | 144.3 | GO:0043204 | perikaryon(GO:0043204) |
1.7 | 152.7 | GO:0005901 | caveola(GO:0005901) |
1.7 | 6.8 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
1.7 | 6.8 | GO:1990131 | Gtr1-Gtr2 GTPase complex(GO:1990131) |
1.7 | 5.0 | GO:0055087 | Ski complex(GO:0055087) |
1.7 | 20.1 | GO:0070765 | gamma-secretase complex(GO:0070765) |
1.7 | 6.6 | GO:0097447 | dendritic tree(GO:0097447) |
1.7 | 3.3 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
1.7 | 3.3 | GO:0034706 | sodium channel complex(GO:0034706) |
1.6 | 4.9 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
1.6 | 261.8 | GO:0005802 | trans-Golgi network(GO:0005802) |
1.6 | 8.0 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
1.6 | 27.1 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
1.6 | 9.5 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
1.6 | 399.0 | GO:0045202 | synapse(GO:0045202) |
1.6 | 78.5 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
1.5 | 15.5 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
1.5 | 10.8 | GO:0005915 | zonula adherens(GO:0005915) |
1.5 | 902.3 | GO:0043005 | neuron projection(GO:0043005) |
1.5 | 1.5 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
1.5 | 4.6 | GO:0016461 | unconventional myosin complex(GO:0016461) |
1.5 | 9.1 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
1.5 | 19.4 | GO:0072546 | ER membrane protein complex(GO:0072546) |
1.5 | 7.4 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
1.4 | 4.3 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
1.4 | 14.2 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
1.4 | 8.4 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
1.4 | 5.6 | GO:0005606 | laminin-1 complex(GO:0005606) |
1.4 | 8.3 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
1.4 | 152.6 | GO:0036477 | somatodendritic compartment(GO:0036477) |
1.4 | 6.8 | GO:0089701 | U2AF(GO:0089701) |
1.3 | 8.0 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
1.3 | 9.2 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) oxoglutarate dehydrogenase complex(GO:0045252) |
1.3 | 3.9 | GO:0001651 | dense fibrillar component(GO:0001651) |
1.3 | 5.2 | GO:1990415 | Pex17p-Pex14p docking complex(GO:1990415) peroxisomal importomer complex(GO:1990429) |
1.3 | 15.5 | GO:0000815 | ESCRT III complex(GO:0000815) |
1.3 | 10.3 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
1.3 | 3.8 | GO:0018444 | translation release factor complex(GO:0018444) |
1.2 | 4.9 | GO:0030891 | VCB complex(GO:0030891) |
1.2 | 1.2 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
1.2 | 7.3 | GO:0097433 | dense body(GO:0097433) |
1.2 | 8.5 | GO:0097165 | nuclear stress granule(GO:0097165) |
1.2 | 6.0 | GO:0031258 | lamellipodium membrane(GO:0031258) |
1.2 | 4.8 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
1.2 | 3.5 | GO:0033263 | CORVET complex(GO:0033263) |
1.2 | 11.7 | GO:0000243 | commitment complex(GO:0000243) |
1.2 | 16.2 | GO:0097431 | mitotic spindle pole(GO:0097431) |
1.2 | 3.5 | GO:0060171 | stereocilium membrane(GO:0060171) |
1.2 | 18.5 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
1.1 | 18.2 | GO:0036379 | striated muscle thin filament(GO:0005865) myofilament(GO:0036379) |
1.1 | 418.6 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
1.1 | 6.7 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
1.1 | 17.9 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
1.1 | 2.2 | GO:0061689 | tricellular tight junction(GO:0061689) |
1.1 | 4.5 | GO:0071942 | XPC complex(GO:0071942) |
1.1 | 31.8 | GO:0005682 | U5 snRNP(GO:0005682) |
1.1 | 6.5 | GO:0097542 | ciliary tip(GO:0097542) |
1.1 | 4.3 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
1.1 | 7.5 | GO:0044853 | plasma membrane raft(GO:0044853) |
1.1 | 6.4 | GO:0070449 | elongin complex(GO:0070449) |
1.1 | 21.2 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
1.1 | 11.6 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
1.0 | 117.7 | GO:0030027 | lamellipodium(GO:0030027) |
1.0 | 9.1 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
1.0 | 1.0 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
1.0 | 2.9 | GO:0060187 | cell pole(GO:0060187) |
1.0 | 8.7 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
1.0 | 4.8 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.9 | 56.6 | GO:0097458 | neuron part(GO:0097458) |
0.9 | 6.6 | GO:1990246 | uniplex complex(GO:1990246) |
0.9 | 21.6 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.9 | 2.8 | GO:0097144 | BAX complex(GO:0097144) |
0.9 | 4.7 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.9 | 7.4 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.9 | 6.5 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.9 | 3.7 | GO:0030870 | Mre11 complex(GO:0030870) |
0.9 | 12.9 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.9 | 2.8 | GO:0000818 | nuclear MIS12/MIND complex(GO:0000818) |
0.9 | 3.6 | GO:1990393 | 3M complex(GO:1990393) |
0.9 | 2.6 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.9 | 7.0 | GO:0070847 | core mediator complex(GO:0070847) |
0.9 | 4.3 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.9 | 3.5 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.9 | 14.6 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.8 | 33.5 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.8 | 1.7 | GO:1990357 | terminal web(GO:1990357) |
0.8 | 3.3 | GO:0032021 | NELF complex(GO:0032021) |
0.8 | 4.1 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.8 | 2.4 | GO:0034066 | RIC1-RGP1 guanyl-nucleotide exchange factor complex(GO:0034066) |
0.8 | 12.7 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.8 | 0.8 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.8 | 12.7 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.8 | 23.7 | GO:0034707 | chloride channel complex(GO:0034707) |
0.8 | 19.5 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.8 | 8.5 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.8 | 10.0 | GO:0016528 | sarcoplasm(GO:0016528) |
0.8 | 6.9 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.8 | 128.5 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.8 | 6.8 | GO:0061700 | Seh1-associated complex(GO:0035859) GATOR2 complex(GO:0061700) |
0.8 | 1.5 | GO:0033185 | mannosyltransferase complex(GO:0031501) dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.8 | 5.3 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.7 | 29.8 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.7 | 2.9 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.7 | 0.7 | GO:0016460 | myosin II complex(GO:0016460) |
0.7 | 43.5 | GO:0005776 | autophagosome(GO:0005776) |
0.7 | 2.8 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
0.7 | 9.2 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.7 | 6.2 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.7 | 17.9 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.7 | 4.8 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.7 | 0.7 | GO:0030315 | T-tubule(GO:0030315) |
0.7 | 8.2 | GO:0031941 | filamentous actin(GO:0031941) |
0.7 | 2.6 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.7 | 17.7 | GO:0030992 | intraciliary transport particle(GO:0030990) intraciliary transport particle B(GO:0030992) |
0.7 | 5.9 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.6 | 19.4 | GO:0031901 | early endosome membrane(GO:0031901) |
0.6 | 11.5 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.6 | 1.9 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.6 | 48.5 | GO:0005774 | vacuolar membrane(GO:0005774) |
0.6 | 3.1 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.6 | 3.7 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.6 | 3.7 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.6 | 1.2 | GO:0005683 | U7 snRNP(GO:0005683) |
0.6 | 5.5 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.6 | 7.2 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.6 | 7.7 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
0.6 | 3.6 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
0.6 | 5.9 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.6 | 5.3 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
0.6 | 13.6 | GO:0044297 | cell body(GO:0044297) |
0.6 | 42.1 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.6 | 2.8 | GO:0033176 | proton-transporting V-type ATPase complex(GO:0033176) |
0.5 | 7.1 | GO:0031201 | SNARE complex(GO:0031201) |
0.5 | 41.5 | GO:0030659 | cytoplasmic vesicle membrane(GO:0030659) |
0.5 | 0.5 | GO:0043291 | RAVE complex(GO:0043291) |
0.5 | 5.4 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.5 | 17.9 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.5 | 184.7 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
0.5 | 19.9 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.5 | 3.0 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
0.5 | 0.5 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.5 | 1.5 | GO:0005916 | fascia adherens(GO:0005916) |
0.5 | 42.4 | GO:0036064 | ciliary basal body(GO:0036064) |
0.5 | 2.4 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.5 | 7.6 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.5 | 233.0 | GO:0005768 | endosome(GO:0005768) |
0.5 | 2.4 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.5 | 3.3 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.5 | 5.6 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.5 | 4.2 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) |
0.5 | 2.3 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.5 | 0.5 | GO:0005715 | late recombination nodule(GO:0005715) |
0.5 | 3.2 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.5 | 4.5 | GO:0042587 | glycogen granule(GO:0042587) |
0.4 | 3.1 | GO:0034709 | methylosome(GO:0034709) |
0.4 | 4.5 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.4 | 3.5 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.4 | 2.2 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.4 | 4.3 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.4 | 3.8 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.4 | 13.8 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) |
0.4 | 2328.7 | GO:0016021 | integral component of membrane(GO:0016021) |
0.4 | 2.1 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.4 | 2.8 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.4 | 0.8 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.4 | 1.2 | GO:0034455 | t-UTP complex(GO:0034455) |
0.4 | 4.6 | GO:0071010 | prespliceosome(GO:0071010) |
0.4 | 2.3 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.4 | 2.3 | GO:1990707 | subtelomeric heterochromatin(GO:1990421) nuclear subtelomeric heterochromatin(GO:1990707) |
0.4 | 1.1 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.3 | 3.1 | GO:0070552 | BRISC complex(GO:0070552) |
0.3 | 5.3 | GO:0005684 | U2-type spliceosomal complex(GO:0005684) |
0.3 | 1.5 | GO:0035363 | histone locus body(GO:0035363) |
0.3 | 6.5 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.3 | 1.8 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.3 | 5.7 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.3 | 26.4 | GO:0030017 | sarcomere(GO:0030017) |
0.3 | 1.3 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.3 | 8.7 | GO:0000139 | Golgi membrane(GO:0000139) |
0.3 | 1.0 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.2 | 2.5 | GO:0036157 | outer dynein arm(GO:0036157) |
0.2 | 8.3 | GO:0005884 | actin filament(GO:0005884) |
0.2 | 1.9 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.2 | 0.2 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.2 | 0.6 | GO:0070992 | translation initiation complex(GO:0070992) |
0.2 | 0.6 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.2 | 1.3 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.2 | 0.4 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.2 | 0.3 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.2 | 0.3 | GO:0005687 | U4 snRNP(GO:0005687) |
0.1 | 0.9 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.1 | 1.0 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.1 | 0.7 | GO:0030427 | site of polarized growth(GO:0030427) |
0.1 | 1.0 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.1 | 0.8 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 0.2 | GO:0017177 | glucosidase II complex(GO:0017177) |
0.0 | 1.5 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 0.4 | GO:0061574 | ASAP complex(GO:0061574) |
0.0 | 0.7 | GO:0030686 | 90S preribosome(GO:0030686) |
0.0 | 0.1 | GO:0097361 | CIA complex(GO:0097361) |
0.0 | 0.1 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.0 | 0.2 | GO:0031082 | BLOC complex(GO:0031082) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
21.2 | 42.4 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
20.5 | 61.5 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
14.2 | 99.4 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
13.5 | 108.0 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
12.9 | 51.8 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
12.4 | 37.2 | GO:0001566 | phorbol ester receptor activity(GO:0001565) non-kinase phorbol ester receptor activity(GO:0001566) |
11.9 | 35.6 | GO:0016492 | G-protein coupled neurotensin receptor activity(GO:0016492) |
11.6 | 116.5 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
11.6 | 69.4 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
11.6 | 69.3 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
11.2 | 44.9 | GO:1902379 | chemoattractant activity involved in axon guidance(GO:1902379) |
11.2 | 78.3 | GO:0031812 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
11.0 | 54.8 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
10.3 | 82.8 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
10.3 | 41.1 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
10.2 | 40.8 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
9.6 | 86.1 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
9.4 | 28.2 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
9.3 | 112.0 | GO:0032051 | clathrin light chain binding(GO:0032051) |
9.3 | 37.1 | GO:0002153 | steroid receptor RNA activator RNA binding(GO:0002153) |
9.1 | 27.3 | GO:0004615 | phosphomannomutase activity(GO:0004615) |
9.0 | 45.0 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
9.0 | 62.8 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
8.9 | 26.8 | GO:0086057 | voltage-gated calcium channel activity involved in bundle of His cell action potential(GO:0086057) |
8.7 | 17.4 | GO:0034437 | glycoprotein transporter activity(GO:0034437) |
8.7 | 26.1 | GO:0051424 | corticotropin-releasing hormone binding(GO:0051424) |
8.6 | 60.5 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
8.5 | 34.2 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
8.5 | 25.5 | GO:0003881 | CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity(GO:0003881) |
8.5 | 33.9 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
8.4 | 42.0 | GO:0099609 | microtubule lateral binding(GO:0099609) |
8.4 | 41.8 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
8.2 | 32.7 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
8.1 | 24.2 | GO:0099530 | PLC activating G-protein coupled glutamate receptor activity(GO:0001639) G-protein coupled receptor activity involved in regulation of postsynaptic membrane potential(GO:0099530) |
8.0 | 80.3 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
8.0 | 79.9 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
7.9 | 55.4 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
7.9 | 23.7 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
7.9 | 39.3 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
7.8 | 46.8 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
7.8 | 23.4 | GO:0098782 | mechanically-gated potassium channel activity(GO:0098782) |
7.7 | 23.2 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
7.5 | 52.8 | GO:0030549 | acetylcholine receptor activator activity(GO:0030549) |
7.5 | 45.0 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
7.1 | 213.5 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
7.1 | 42.5 | GO:0097643 | amylin receptor activity(GO:0097643) |
7.0 | 83.9 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
7.0 | 27.9 | GO:0045183 | translation factor activity, non-nucleic acid binding(GO:0045183) |
7.0 | 97.4 | GO:0051378 | serotonin binding(GO:0051378) |
6.9 | 20.7 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
6.9 | 55.0 | GO:0034235 | GPI anchor binding(GO:0034235) |
6.8 | 27.3 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) |
6.7 | 73.9 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
6.6 | 33.1 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
6.6 | 26.5 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
6.6 | 19.8 | GO:0004962 | endothelin receptor activity(GO:0004962) |
6.6 | 59.1 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
6.5 | 97.8 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
6.4 | 19.2 | GO:0031687 | A2A adenosine receptor binding(GO:0031687) |
6.4 | 70.4 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
6.4 | 31.8 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
6.3 | 31.6 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
6.3 | 44.3 | GO:0004111 | creatine kinase activity(GO:0004111) |
6.3 | 139.0 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
6.3 | 88.4 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
6.3 | 25.2 | GO:0005093 | Rab GDP-dissociation inhibitor activity(GO:0005093) |
6.3 | 25.1 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
6.2 | 24.8 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
6.2 | 62.0 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
6.2 | 18.5 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
6.1 | 6.1 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
6.0 | 35.8 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
5.9 | 29.3 | GO:0097001 | ceramide binding(GO:0097001) |
5.8 | 5.8 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
5.8 | 46.5 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
5.8 | 29.0 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
5.8 | 40.5 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
5.8 | 46.3 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
5.8 | 75.0 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
5.7 | 28.7 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
5.7 | 34.4 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
5.7 | 34.4 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
5.7 | 28.5 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
5.6 | 186.4 | GO:0048156 | tau protein binding(GO:0048156) |
5.5 | 55.2 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
5.5 | 82.0 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
5.4 | 37.8 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
5.4 | 48.6 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
5.3 | 16.0 | GO:0051380 | norepinephrine binding(GO:0051380) |
5.3 | 16.0 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
5.3 | 21.2 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
5.3 | 142.6 | GO:0031489 | myosin V binding(GO:0031489) |
5.3 | 15.8 | GO:0004421 | hydroxymethylglutaryl-CoA synthase activity(GO:0004421) |
5.3 | 36.9 | GO:0004985 | opioid receptor activity(GO:0004985) |
5.3 | 15.8 | GO:0004471 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
5.3 | 110.3 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
5.2 | 5.2 | GO:0048030 | disaccharide binding(GO:0048030) |
5.2 | 15.7 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
5.2 | 26.1 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
5.2 | 26.1 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
5.2 | 31.0 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
5.1 | 46.2 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
5.0 | 39.7 | GO:0005042 | netrin receptor activity(GO:0005042) |
4.9 | 14.8 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
4.9 | 44.4 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
4.8 | 48.5 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
4.8 | 28.9 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
4.8 | 105.8 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
4.7 | 4.7 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) |
4.7 | 18.7 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
4.7 | 37.4 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
4.7 | 112.1 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
4.7 | 83.8 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
4.7 | 14.0 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
4.6 | 50.9 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
4.6 | 74.0 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
4.5 | 81.6 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
4.5 | 4.5 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
4.5 | 18.0 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
4.5 | 17.9 | GO:0042806 | fucose binding(GO:0042806) |
4.4 | 17.7 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
4.4 | 22.1 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
4.4 | 17.6 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
4.4 | 13.1 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
4.3 | 4.3 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
4.3 | 369.2 | GO:0035254 | glutamate receptor binding(GO:0035254) |
4.3 | 43.4 | GO:0070324 | thyroid hormone binding(GO:0070324) |
4.3 | 86.5 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
4.3 | 17.3 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
4.3 | 12.9 | GO:0005308 | creatine transmembrane transporter activity(GO:0005308) |
4.2 | 16.9 | GO:0004736 | pyruvate carboxylase activity(GO:0004736) |
4.2 | 29.4 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
4.2 | 20.9 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
4.2 | 54.3 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
4.2 | 12.5 | GO:0004373 | glycogen (starch) synthase activity(GO:0004373) |
4.1 | 29.0 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
4.1 | 45.4 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
4.1 | 481.1 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
4.1 | 16.4 | GO:0051381 | histamine binding(GO:0051381) |
4.1 | 16.4 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
4.1 | 28.6 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
4.1 | 36.7 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
4.1 | 40.8 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
4.1 | 138.0 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
4.1 | 231.0 | GO:0001540 | beta-amyloid binding(GO:0001540) |
4.0 | 20.2 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
4.0 | 7.9 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
3.9 | 39.4 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
3.9 | 7.9 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
3.9 | 19.5 | GO:0048495 | Roundabout binding(GO:0048495) |
3.9 | 74.1 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
3.9 | 11.7 | GO:0010428 | methyl-CpNpG binding(GO:0010428) |
3.9 | 19.5 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
3.9 | 15.5 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
3.9 | 57.8 | GO:0042043 | neurexin family protein binding(GO:0042043) |
3.9 | 11.6 | GO:0070025 | cystathionine beta-synthase activity(GO:0004122) oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) nitrite reductase (NO-forming) activity(GO:0050421) carbon monoxide binding(GO:0070025) nitric oxide binding(GO:0070026) |
3.9 | 119.4 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
3.8 | 11.5 | GO:1990698 | palmitoleoyltransferase activity(GO:1990698) |
3.8 | 42.2 | GO:0004017 | adenylate kinase activity(GO:0004017) |
3.8 | 3.8 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
3.8 | 11.5 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
3.8 | 15.3 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
3.8 | 11.4 | GO:0016232 | HNK-1 sulfotransferase activity(GO:0016232) |
3.8 | 22.7 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
3.7 | 29.8 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
3.7 | 26.0 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
3.7 | 137.0 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
3.7 | 22.0 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
3.6 | 10.9 | GO:0001888 | glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0001888) |
3.6 | 25.5 | GO:0008486 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) |
3.6 | 18.2 | GO:0019992 | diacylglycerol binding(GO:0019992) |
3.6 | 14.5 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
3.6 | 21.6 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
3.5 | 3.5 | GO:0033142 | progesterone receptor binding(GO:0033142) |
3.5 | 10.6 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
3.5 | 17.6 | GO:0051425 | PTB domain binding(GO:0051425) |
3.5 | 10.6 | GO:0016657 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
3.5 | 56.3 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
3.5 | 284.7 | GO:0030276 | clathrin binding(GO:0030276) |
3.5 | 35.1 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
3.5 | 90.8 | GO:0004629 | phospholipase C activity(GO:0004629) |
3.5 | 7.0 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
3.5 | 31.3 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
3.5 | 24.3 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
3.5 | 62.1 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
3.4 | 243.2 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
3.4 | 27.2 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
3.4 | 67.6 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
3.4 | 242.3 | GO:0019894 | kinesin binding(GO:0019894) |
3.3 | 13.4 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
3.3 | 10.0 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
3.3 | 13.2 | GO:0030156 | benzodiazepine receptor binding(GO:0030156) |
3.3 | 13.2 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
3.3 | 13.2 | GO:0097016 | L27 domain binding(GO:0097016) |
3.3 | 95.3 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
3.3 | 16.4 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
3.3 | 143.1 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
3.2 | 12.9 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
3.2 | 16.0 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
3.2 | 9.6 | GO:0016213 | linoleoyl-CoA desaturase activity(GO:0016213) |
3.2 | 12.6 | GO:0004161 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
3.1 | 9.4 | GO:0047756 | chondroitin sulfotransferase activity(GO:0034481) chondroitin 4-sulfotransferase activity(GO:0047756) |
3.1 | 12.6 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
3.1 | 9.4 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
3.1 | 219.0 | GO:0030507 | spectrin binding(GO:0030507) |
3.1 | 9.3 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
3.1 | 9.3 | GO:0004420 | hydroxymethylglutaryl-CoA reductase (NADPH) activity(GO:0004420) hydroxymethylglutaryl-CoA reductase activity(GO:0042282) |
3.0 | 45.7 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
3.0 | 12.2 | GO:0003883 | CTP synthase activity(GO:0003883) |
3.0 | 15.1 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
2.9 | 43.9 | GO:0015026 | coreceptor activity(GO:0015026) |
2.9 | 38.0 | GO:0005003 | ephrin receptor activity(GO:0005003) |
2.9 | 23.4 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
2.9 | 8.7 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
2.9 | 8.7 | GO:0004155 | 6,7-dihydropteridine reductase activity(GO:0004155) |
2.9 | 14.5 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
2.9 | 14.5 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
2.9 | 23.1 | GO:1903136 | cuprous ion binding(GO:1903136) |
2.9 | 2.9 | GO:0005330 | dopamine:sodium symporter activity(GO:0005330) |
2.9 | 20.2 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
2.9 | 2.9 | GO:0001032 | RNA polymerase III type 3 promoter DNA binding(GO:0001032) |
2.8 | 2.8 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
2.8 | 14.2 | GO:0016499 | orexin receptor activity(GO:0016499) |
2.8 | 11.4 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
2.8 | 2.8 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
2.8 | 56.2 | GO:0004707 | MAP kinase activity(GO:0004707) |
2.8 | 14.0 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
2.8 | 11.2 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
2.8 | 8.3 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
2.8 | 8.3 | GO:0004132 | dCMP deaminase activity(GO:0004132) |
2.7 | 10.9 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
2.7 | 5.4 | GO:0032129 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
2.7 | 8.1 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
2.7 | 8.1 | GO:0017049 | GTP-Rho binding(GO:0017049) |
2.7 | 13.3 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
2.6 | 37.1 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
2.6 | 7.9 | GO:0004969 | histamine receptor activity(GO:0004969) |
2.6 | 7.9 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
2.6 | 23.5 | GO:0070097 | delta-catenin binding(GO:0070097) |
2.6 | 15.6 | GO:0031013 | troponin I binding(GO:0031013) |
2.6 | 41.3 | GO:0005522 | profilin binding(GO:0005522) |
2.6 | 7.7 | GO:0005148 | prolactin receptor binding(GO:0005148) |
2.6 | 5.1 | GO:0047237 | glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047237) |
2.5 | 7.6 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
2.5 | 5.0 | GO:0002135 | CTP binding(GO:0002135) |
2.5 | 10.1 | GO:0004816 | asparagine-tRNA ligase activity(GO:0004816) |
2.5 | 7.5 | GO:0030622 | U4atac snRNA binding(GO:0030622) |
2.5 | 15.0 | GO:0098821 | BMP receptor activity(GO:0098821) |
2.5 | 50.0 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
2.5 | 27.4 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
2.5 | 7.4 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
2.5 | 42.1 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
2.5 | 2.5 | GO:0016418 | S-acetyltransferase activity(GO:0016418) |
2.4 | 17.1 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
2.4 | 4.9 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
2.4 | 7.3 | GO:0001847 | opsonin receptor activity(GO:0001847) |
2.4 | 48.6 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
2.4 | 29.2 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
2.4 | 7.3 | GO:0036361 | racemase and epimerase activity, acting on amino acids and derivatives(GO:0016855) racemase activity, acting on amino acids and derivatives(GO:0036361) amino-acid racemase activity(GO:0047661) |
2.4 | 101.4 | GO:0019905 | syntaxin binding(GO:0019905) |
2.4 | 7.2 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
2.4 | 7.2 | GO:0004958 | prostaglandin F receptor activity(GO:0004958) |
2.4 | 7.2 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
2.4 | 9.5 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
2.4 | 7.1 | GO:0035939 | microsatellite binding(GO:0035939) |
2.3 | 60.9 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
2.3 | 7.0 | GO:0015292 | uniporter activity(GO:0015292) |
2.3 | 9.3 | GO:0015410 | manganese-transporting ATPase activity(GO:0015410) |
2.3 | 287.6 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
2.3 | 2.3 | GO:0050436 | microfibril binding(GO:0050436) |
2.3 | 16.2 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
2.3 | 6.9 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
2.3 | 9.2 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
2.3 | 6.9 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
2.3 | 2.3 | GO:0004819 | glutamine-tRNA ligase activity(GO:0004819) |
2.3 | 11.5 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
2.3 | 36.3 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
2.2 | 13.5 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
2.2 | 76.1 | GO:0017147 | Wnt-protein binding(GO:0017147) |
2.2 | 6.7 | GO:0019002 | GMP binding(GO:0019002) |
2.2 | 15.6 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
2.2 | 6.7 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
2.2 | 61.8 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
2.2 | 21.8 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
2.2 | 24.0 | GO:0015217 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
2.2 | 4.4 | GO:0001129 | RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly(GO:0001129) RNA polymerase II transcription factor activity, TBP-class protein binding(GO:0001132) |
2.2 | 8.7 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
2.1 | 21.5 | GO:0071253 | connexin binding(GO:0071253) |
2.1 | 12.9 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
2.1 | 21.5 | GO:0033691 | sialic acid binding(GO:0033691) |
2.1 | 6.4 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
2.1 | 12.8 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
2.1 | 4.2 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
2.1 | 6.4 | GO:0016901 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
2.1 | 4.2 | GO:0034452 | dynactin binding(GO:0034452) |
2.1 | 8.4 | GO:0070051 | fibrinogen binding(GO:0070051) |
2.1 | 33.7 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
2.1 | 50.2 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
2.1 | 12.5 | GO:0038132 | neuregulin binding(GO:0038132) |
2.1 | 8.3 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
2.1 | 12.4 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
2.1 | 6.2 | GO:0001156 | TFIIIC-class transcription factor binding(GO:0001156) |
2.1 | 6.2 | GO:0005135 | interleukin-3 receptor binding(GO:0005135) |
2.1 | 41.3 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
2.1 | 39.2 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
2.1 | 14.4 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
2.1 | 6.2 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
2.0 | 18.4 | GO:0005272 | sodium channel activity(GO:0005272) |
2.0 | 12.2 | GO:0000828 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
2.0 | 61.2 | GO:0005484 | SNAP receptor activity(GO:0005484) |
2.0 | 4.1 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
2.0 | 2.0 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
2.0 | 16.2 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
2.0 | 14.2 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
2.0 | 2.0 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
2.0 | 34.3 | GO:0005523 | tropomyosin binding(GO:0005523) |
2.0 | 2.0 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
2.0 | 14.0 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
2.0 | 28.0 | GO:0005243 | gap junction channel activity(GO:0005243) |
2.0 | 24.0 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
2.0 | 35.9 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) |
2.0 | 21.9 | GO:0070700 | BMP receptor binding(GO:0070700) |
2.0 | 10.0 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
2.0 | 15.9 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
2.0 | 2.0 | GO:0002046 | opsin binding(GO:0002046) |
2.0 | 19.7 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
2.0 | 7.9 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
2.0 | 7.8 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
2.0 | 5.9 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
2.0 | 7.8 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
1.9 | 19.5 | GO:0038191 | neuropilin binding(GO:0038191) |
1.9 | 218.5 | GO:0044325 | ion channel binding(GO:0044325) |
1.9 | 5.7 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
1.9 | 3.8 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
1.9 | 5.7 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
1.9 | 9.5 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
1.9 | 11.5 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
1.9 | 19.1 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
1.9 | 22.9 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
1.9 | 5.7 | GO:0031768 | ghrelin receptor binding(GO:0031768) |
1.9 | 13.3 | GO:0005119 | smoothened binding(GO:0005119) |
1.9 | 11.3 | GO:0070538 | oleic acid binding(GO:0070538) |
1.9 | 7.5 | GO:0004779 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
1.9 | 26.3 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
1.9 | 1.9 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
1.9 | 22.5 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
1.9 | 11.2 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
1.9 | 5.6 | GO:0090555 | phosphatidylethanolamine-translocating ATPase activity(GO:0090555) |
1.9 | 29.7 | GO:0001083 | transcription factor activity, RNA polymerase II basal transcription factor binding(GO:0001083) |
1.9 | 1.9 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) |
1.9 | 27.8 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
1.9 | 14.8 | GO:0032184 | SUMO polymer binding(GO:0032184) |
1.8 | 55.3 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
1.8 | 7.4 | GO:0019970 | interleukin-11 receptor activity(GO:0004921) interleukin-11 binding(GO:0019970) |
1.8 | 55.0 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
1.8 | 7.3 | GO:0001849 | complement component C1q binding(GO:0001849) |
1.8 | 3.6 | GO:0032564 | dATP binding(GO:0032564) |
1.8 | 10.8 | GO:0005217 | intracellular ligand-gated ion channel activity(GO:0005217) calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
1.8 | 59.5 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
1.8 | 7.2 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
1.8 | 17.9 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
1.8 | 5.4 | GO:0004493 | methylmalonyl-CoA epimerase activity(GO:0004493) |
1.8 | 5.3 | GO:0016015 | morphogen activity(GO:0016015) |
1.8 | 156.1 | GO:0005518 | collagen binding(GO:0005518) |
1.8 | 7.1 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
1.8 | 5.3 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
1.8 | 14.1 | GO:0050815 | phosphoserine binding(GO:0050815) |
1.8 | 3.5 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
1.8 | 49.2 | GO:0097602 | cullin family protein binding(GO:0097602) |
1.7 | 7.0 | GO:0047710 | bis(5'-adenosyl)-triphosphatase activity(GO:0047710) |
1.7 | 40.1 | GO:0031005 | filamin binding(GO:0031005) |
1.7 | 13.9 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
1.7 | 41.7 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
1.7 | 5.2 | GO:0004135 | glycogen debranching enzyme activity(GO:0004133) 4-alpha-glucanotransferase activity(GO:0004134) amylo-alpha-1,6-glucosidase activity(GO:0004135) |
1.7 | 5.2 | GO:0052895 | norspermine:oxygen oxidoreductase activity(GO:0052894) N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity(GO:0052895) |
1.7 | 5.2 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
1.7 | 10.3 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
1.7 | 13.8 | GO:0019158 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
1.7 | 8.6 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
1.7 | 5.1 | GO:0043532 | angiostatin binding(GO:0043532) |
1.7 | 5.1 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
1.7 | 59.7 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
1.7 | 10.2 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
1.7 | 6.8 | GO:0017166 | vinculin binding(GO:0017166) |
1.7 | 5.1 | GO:0030911 | TPR domain binding(GO:0030911) |
1.7 | 6.8 | GO:0033883 | pyridoxal phosphatase activity(GO:0033883) |
1.7 | 6.7 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
1.7 | 25.0 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
1.7 | 5.0 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
1.7 | 5.0 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
1.7 | 29.7 | GO:0044548 | S100 protein binding(GO:0044548) |
1.6 | 1.6 | GO:0008556 | potassium-transporting ATPase activity(GO:0008556) |
1.6 | 3.3 | GO:0003990 | acetylcholinesterase activity(GO:0003990) |
1.6 | 3.3 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
1.6 | 4.9 | GO:0005011 | macrophage colony-stimulating factor receptor activity(GO:0005011) |
1.6 | 6.6 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
1.6 | 32.3 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
1.6 | 4.8 | GO:0004658 | propionyl-CoA carboxylase activity(GO:0004658) |
1.6 | 1.6 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
1.6 | 4.8 | GO:1990931 | oxidative DNA demethylase activity(GO:0035516) RNA N6-methyladenosine dioxygenase activity(GO:1990931) |
1.6 | 194.4 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
1.6 | 4.8 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
1.6 | 27.2 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
1.6 | 8.0 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
1.6 | 7.9 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
1.6 | 1.6 | GO:0016898 | D-lactate dehydrogenase (cytochrome) activity(GO:0004458) oxidoreductase activity, acting on the CH-OH group of donors, cytochrome as acceptor(GO:0016898) |
1.6 | 6.3 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
1.6 | 1.6 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
1.6 | 12.6 | GO:0052654 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
1.6 | 12.6 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
1.6 | 26.8 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
1.6 | 9.4 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
1.6 | 11.0 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
1.6 | 10.9 | GO:0004659 | prenyltransferase activity(GO:0004659) |
1.6 | 12.4 | GO:0004065 | arylsulfatase activity(GO:0004065) |
1.5 | 9.3 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
1.5 | 23.2 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
1.5 | 15.4 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
1.5 | 15.4 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
1.5 | 10.7 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
1.5 | 7.7 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
1.5 | 9.2 | GO:0008066 | glutamate receptor activity(GO:0008066) |
1.5 | 16.7 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
1.5 | 119.8 | GO:0005080 | protein kinase C binding(GO:0005080) |
1.5 | 78.0 | GO:0005158 | insulin receptor binding(GO:0005158) |
1.5 | 4.5 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
1.5 | 9.0 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
1.5 | 4.5 | GO:0008160 | protein tyrosine phosphatase activator activity(GO:0008160) protein phosphatase activator activity(GO:0072542) |
1.5 | 7.4 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
1.5 | 53.3 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
1.5 | 4.4 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
1.5 | 2.9 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
1.5 | 73.7 | GO:0046875 | ephrin receptor binding(GO:0046875) |
1.5 | 69.2 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
1.5 | 4.4 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
1.5 | 4.4 | GO:0042936 | dipeptide transporter activity(GO:0042936) |
1.5 | 14.7 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
1.5 | 51.1 | GO:0005109 | frizzled binding(GO:0005109) |
1.5 | 2.9 | GO:0043199 | sulfate binding(GO:0043199) |
1.5 | 8.7 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
1.5 | 27.6 | GO:0042165 | neurotransmitter binding(GO:0042165) |
1.5 | 4.4 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
1.5 | 16.0 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
1.5 | 14.5 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
1.4 | 4.3 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
1.4 | 5.8 | GO:0008802 | betaine-aldehyde dehydrogenase activity(GO:0008802) |
1.4 | 25.9 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
1.4 | 31.4 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
1.4 | 32.7 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
1.4 | 32.7 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
1.4 | 4.3 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
1.4 | 9.9 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
1.4 | 7.1 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
1.4 | 5.6 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
1.4 | 21.2 | GO:0042923 | neuropeptide binding(GO:0042923) |
1.4 | 5.6 | GO:0008493 | tetracycline transporter activity(GO:0008493) |
1.4 | 5.6 | GO:0000010 | trans-hexaprenyltranstransferase activity(GO:0000010) trans-octaprenyltranstransferase activity(GO:0050347) |
1.4 | 11.2 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
1.4 | 13.9 | GO:0045118 | azole transporter activity(GO:0045118) |
1.4 | 25.0 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
1.4 | 63.4 | GO:0048365 | Rac GTPase binding(GO:0048365) |
1.4 | 19.2 | GO:0045499 | chemorepellent activity(GO:0045499) |
1.4 | 16.4 | GO:0004112 | cyclic-nucleotide phosphodiesterase activity(GO:0004112) |
1.4 | 12.3 | GO:0050811 | GABA receptor binding(GO:0050811) |
1.4 | 30.0 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
1.4 | 5.4 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
1.4 | 17.6 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
1.3 | 52.6 | GO:0050840 | extracellular matrix binding(GO:0050840) |
1.3 | 13.4 | GO:0008081 | phosphoric diester hydrolase activity(GO:0008081) |
1.3 | 415.4 | GO:0015631 | tubulin binding(GO:0015631) |
1.3 | 9.2 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
1.3 | 7.9 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
1.3 | 5.2 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
1.3 | 1.3 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
1.3 | 7.8 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
1.3 | 3.9 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
1.3 | 5.1 | GO:0003998 | acylphosphatase activity(GO:0003998) |
1.3 | 12.8 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
1.3 | 11.3 | GO:0005344 | oxygen transporter activity(GO:0005344) |
1.2 | 2.5 | GO:0042289 | MHC class II protein binding(GO:0042289) |
1.2 | 2.5 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
1.2 | 7.4 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
1.2 | 3.7 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
1.2 | 4.9 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
1.2 | 14.7 | GO:0008061 | chitin binding(GO:0008061) |
1.2 | 3.6 | GO:0047598 | sterol delta7 reductase activity(GO:0009918) 7-dehydrocholesterol reductase activity(GO:0047598) |
1.2 | 9.7 | GO:0015288 | porin activity(GO:0015288) |
1.2 | 53.2 | GO:0016247 | channel regulator activity(GO:0016247) |
1.2 | 3.6 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
1.2 | 21.6 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
1.2 | 2.4 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
1.2 | 10.8 | GO:0050897 | cobalt ion binding(GO:0050897) |
1.2 | 7.1 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
1.2 | 4.7 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
1.2 | 7.1 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
1.2 | 3.5 | GO:0008119 | thiopurine S-methyltransferase activity(GO:0008119) |
1.2 | 12.8 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
1.2 | 4.6 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
1.2 | 2.3 | GO:0050816 | phosphothreonine binding(GO:0050816) |
1.1 | 3.4 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
1.1 | 4.5 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
1.1 | 45.3 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
1.1 | 3.4 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
1.1 | 50.4 | GO:0017022 | myosin binding(GO:0017022) |
1.1 | 8.8 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
1.1 | 267.1 | GO:0003924 | GTPase activity(GO:0003924) |
1.1 | 3.3 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
1.1 | 18.4 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
1.1 | 7.6 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
1.1 | 7.6 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
1.1 | 5.4 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
1.1 | 1.1 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
1.1 | 21.2 | GO:0008517 | folic acid transporter activity(GO:0008517) |
1.1 | 37.0 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
1.1 | 4.2 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
1.0 | 31.1 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
1.0 | 17.6 | GO:0030275 | LRR domain binding(GO:0030275) |
1.0 | 7.2 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
1.0 | 591.7 | GO:0005509 | calcium ion binding(GO:0005509) |
1.0 | 5.1 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
1.0 | 4.1 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
1.0 | 1.0 | GO:1990955 | G-rich single-stranded DNA binding(GO:1990955) |
1.0 | 17.3 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
1.0 | 4.0 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
1.0 | 13.1 | GO:0030957 | Tat protein binding(GO:0030957) |
1.0 | 3.0 | GO:0004821 | histidine-tRNA ligase activity(GO:0004821) |
1.0 | 27.2 | GO:0050681 | androgen receptor binding(GO:0050681) |
1.0 | 7.0 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
1.0 | 2.0 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
1.0 | 60.9 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
1.0 | 10.0 | GO:0043426 | MRF binding(GO:0043426) |
1.0 | 2.0 | GO:0001034 | RNA polymerase III transcription factor activity, sequence-specific DNA binding(GO:0001034) |
1.0 | 44.9 | GO:0050699 | WW domain binding(GO:0050699) |
1.0 | 2.0 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
1.0 | 8.9 | GO:0050733 | RS domain binding(GO:0050733) |
1.0 | 7.9 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
1.0 | 3.0 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
1.0 | 3.0 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
1.0 | 2.9 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
1.0 | 2.9 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
1.0 | 15.6 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
1.0 | 6.8 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
1.0 | 16.4 | GO:0017048 | Rho GTPase binding(GO:0017048) |
1.0 | 11.6 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
1.0 | 6.7 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
1.0 | 8.6 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
1.0 | 2.9 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
1.0 | 5.7 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
1.0 | 4.8 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.9 | 11.3 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.9 | 3.8 | GO:0016708 | nitric oxide dioxygenase activity(GO:0008941) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor(GO:0016708) iron-cytochrome-c reductase activity(GO:0047726) |
0.9 | 4.6 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.9 | 0.9 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
0.9 | 3.6 | GO:0008176 | tRNA (guanine-N7-)-methyltransferase activity(GO:0008176) |
0.9 | 3.6 | GO:0042731 | PH domain binding(GO:0042731) |
0.9 | 1.8 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.9 | 3.6 | GO:0072541 | peroxynitrite reductase activity(GO:0072541) |
0.9 | 0.9 | GO:0008988 | rRNA (adenine-N6-)-methyltransferase activity(GO:0008988) |
0.9 | 1.8 | GO:0004088 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
0.9 | 1.8 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
0.9 | 7.0 | GO:1990190 | peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.9 | 5.2 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.9 | 2.6 | GO:0033858 | N-acetylgalactosamine kinase activity(GO:0033858) |
0.9 | 3.5 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.9 | 6.1 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
0.9 | 12.1 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.9 | 5.2 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.9 | 18.1 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.9 | 5.2 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.9 | 3.4 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.9 | 15.3 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.8 | 4.2 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.8 | 5.1 | GO:0070004 | cysteine-type carboxypeptidase activity(GO:0016807) cysteine-type exopeptidase activity(GO:0070004) |
0.8 | 3.4 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.8 | 2.5 | GO:0008396 | oxysterol 7-alpha-hydroxylase activity(GO:0008396) |
0.8 | 2.5 | GO:0036033 | mediator complex binding(GO:0036033) |
0.8 | 1.7 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.8 | 22.5 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.8 | 1.7 | GO:0090556 | apolipoprotein receptor activity(GO:0030226) apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
0.8 | 13.3 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.8 | 4.9 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.8 | 0.8 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.8 | 2.4 | GO:0052692 | raffinose alpha-galactosidase activity(GO:0052692) |
0.8 | 1.6 | GO:0038100 | nodal binding(GO:0038100) |
0.8 | 5.7 | GO:0000182 | rDNA binding(GO:0000182) |
0.8 | 4.8 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
0.8 | 0.8 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.8 | 15.9 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
0.8 | 32.3 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.8 | 3.9 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.8 | 2.4 | GO:0004822 | isoleucine-tRNA ligase activity(GO:0004822) |
0.8 | 10.1 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.8 | 1.6 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.8 | 3.9 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.8 | 223.4 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.8 | 10.6 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
0.8 | 6.8 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.8 | 20.3 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.7 | 2.2 | GO:0050479 | glyceryl-ether monooxygenase activity(GO:0050479) |
0.7 | 12.6 | GO:0015643 | toxic substance binding(GO:0015643) |
0.7 | 2.2 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.7 | 13.3 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.7 | 3.7 | GO:0004452 | isopentenyl-diphosphate delta-isomerase activity(GO:0004452) |
0.7 | 22.0 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.7 | 10.9 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.7 | 6.5 | GO:0016151 | nickel cation binding(GO:0016151) |
0.7 | 2.2 | GO:0036080 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
0.7 | 39.6 | GO:0051117 | ATPase binding(GO:0051117) |
0.7 | 2.2 | GO:0016433 | rRNA (adenine) methyltransferase activity(GO:0016433) |
0.7 | 18.0 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.7 | 21.5 | GO:0071949 | FAD binding(GO:0071949) |
0.7 | 3.6 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.7 | 2.8 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.7 | 5.0 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
0.7 | 2.1 | GO:1990259 | protein-glutamine N-methyltransferase activity(GO:0036009) histone-glutamine methyltransferase activity(GO:1990259) |
0.7 | 8.4 | GO:1901981 | phosphatidylinositol phosphate binding(GO:1901981) |
0.7 | 2.1 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.7 | 0.7 | GO:0008169 | C-methyltransferase activity(GO:0008169) rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
0.7 | 4.2 | GO:0004359 | glutaminase activity(GO:0004359) |
0.7 | 3.4 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.7 | 4.8 | GO:0034046 | poly(G) binding(GO:0034046) |
0.7 | 2.1 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
0.7 | 53.9 | GO:0035091 | phosphatidylinositol binding(GO:0035091) |
0.7 | 2.0 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
0.7 | 2.0 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.7 | 6.7 | GO:0005112 | Notch binding(GO:0005112) |
0.7 | 4.0 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.7 | 1.3 | GO:0036122 | BMP binding(GO:0036122) |
0.7 | 9.1 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.7 | 5.9 | GO:0010181 | FMN binding(GO:0010181) |
0.6 | 3.2 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.6 | 1.9 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.6 | 1.3 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.6 | 1.9 | GO:0050510 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.6 | 5.0 | GO:0016653 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
0.6 | 1.9 | GO:0004613 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
0.6 | 2.5 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.6 | 1.2 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.6 | 14.7 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.6 | 5.5 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) |
0.6 | 9.1 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.6 | 1.8 | GO:0035730 | S-nitrosoglutathione binding(GO:0035730) dinitrosyl-iron complex binding(GO:0035731) |
0.6 | 68.6 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.6 | 78.0 | GO:0051015 | actin filament binding(GO:0051015) |
0.6 | 8.3 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.6 | 1.2 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.6 | 2.9 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.6 | 2.3 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
0.6 | 3.4 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.6 | 1.7 | GO:0047291 | lactosylceramide alpha-2,3-sialyltransferase activity(GO:0047291) |
0.6 | 2.8 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.6 | 7.9 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.6 | 2.8 | GO:0102345 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.6 | 1.7 | GO:0019807 | aspartoacylase activity(GO:0019807) |
0.5 | 0.5 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.5 | 4.4 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
0.5 | 5.5 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.5 | 32.3 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.5 | 0.5 | GO:0003681 | bent DNA binding(GO:0003681) |
0.5 | 2.7 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.5 | 8.0 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.5 | 3.2 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.5 | 12.2 | GO:0043394 | proteoglycan binding(GO:0043394) |
0.5 | 5.8 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.5 | 5.8 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.5 | 78.9 | GO:0008022 | protein C-terminus binding(GO:0008022) |
0.5 | 12.7 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.5 | 2.1 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.5 | 24.6 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.5 | 2.6 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.5 | 44.9 | GO:0005525 | GTP binding(GO:0005525) |
0.5 | 1.5 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.5 | 1.5 | GO:0004557 | alpha-galactosidase activity(GO:0004557) |
0.5 | 0.5 | GO:0008469 | histone-arginine N-methyltransferase activity(GO:0008469) |
0.5 | 6.3 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.5 | 2.9 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.5 | 1.4 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.5 | 14.8 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
0.5 | 8.1 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
0.5 | 1.4 | GO:0004968 | gonadotropin-releasing hormone receptor activity(GO:0004968) |
0.5 | 23.0 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.5 | 4.6 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.5 | 4.6 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.5 | 2.3 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.5 | 1.4 | GO:0016900 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
0.5 | 2.7 | GO:0070840 | dynein complex binding(GO:0070840) |
0.5 | 5.0 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.4 | 1.3 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.4 | 39.5 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.4 | 0.9 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.4 | 5.6 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.4 | 3.5 | GO:0017040 | ceramidase activity(GO:0017040) |
0.4 | 5.6 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.4 | 1.3 | GO:0004001 | adenosine kinase activity(GO:0004001) |
0.4 | 0.8 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.4 | 5.5 | GO:0070402 | NADPH binding(GO:0070402) |
0.4 | 1.3 | GO:0071796 | K6-linked polyubiquitin binding(GO:0071796) |
0.4 | 15.1 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.4 | 1.3 | GO:0016979 | lipoate-protein ligase activity(GO:0016979) |
0.4 | 11.6 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.4 | 26.0 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.4 | 2.1 | GO:0004145 | diamine N-acetyltransferase activity(GO:0004145) |
0.4 | 2.0 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.4 | 1.6 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.4 | 1.2 | GO:0019150 | D-ribulokinase activity(GO:0019150) |
0.4 | 1.9 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.4 | 0.7 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.4 | 1.1 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
0.4 | 1.8 | GO:0009384 | UDP-N-acetylglucosamine 2-epimerase activity(GO:0008761) N-acylmannosamine kinase activity(GO:0009384) |
0.4 | 1.1 | GO:0003977 | UDP-N-acetylglucosamine diphosphorylase activity(GO:0003977) |
0.4 | 173.9 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.4 | 1.4 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.4 | 1.4 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.4 | 4.2 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.3 | 1.0 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.3 | 1.0 | GO:0001962 | alpha-1,3-galactosyltransferase activity(GO:0001962) |
0.3 | 1.4 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.3 | 2.0 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.3 | 5.7 | GO:0000149 | SNARE binding(GO:0000149) |
0.3 | 22.1 | GO:0002039 | p53 binding(GO:0002039) |
0.3 | 1.7 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.3 | 1.0 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.3 | 1.3 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.3 | 9.6 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.3 | 1.3 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.3 | 0.6 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.3 | 1.3 | GO:0032093 | SAM domain binding(GO:0032093) |
0.3 | 1.6 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.3 | 1.2 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.3 | 0.9 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
0.3 | 1.2 | GO:0047874 | dolichyldiphosphatase activity(GO:0047874) |
0.3 | 2.4 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.3 | 3.1 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.3 | 2.3 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.3 | 0.9 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
0.3 | 0.9 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
0.3 | 1.1 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.3 | 3.1 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.3 | 10.3 | GO:0000049 | tRNA binding(GO:0000049) |
0.3 | 0.3 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.3 | 2.2 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.3 | 1.4 | GO:0016723 | oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor(GO:0016723) |
0.3 | 1.1 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.3 | 1.1 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.3 | 1.3 | GO:2001069 | glycogen binding(GO:2001069) |
0.3 | 1.3 | GO:1990188 | euchromatin binding(GO:1990188) |
0.3 | 1.6 | GO:0004487 | methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.3 | 1.6 | GO:0045545 | syndecan binding(GO:0045545) |
0.3 | 0.8 | GO:0033754 | indoleamine 2,3-dioxygenase activity(GO:0033754) |
0.3 | 5.8 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.2 | 1.7 | GO:0000150 | recombinase activity(GO:0000150) |
0.2 | 0.2 | GO:0001729 | ceramide kinase activity(GO:0001729) |
0.2 | 0.7 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
0.2 | 1.1 | GO:0072590 | N-acetyl-L-aspartate-L-glutamate ligase activity(GO:0072590) |
0.2 | 0.7 | GO:0008124 | 4-alpha-hydroxytetrahydrobiopterin dehydratase activity(GO:0008124) |
0.2 | 0.4 | GO:0030519 | snoRNP binding(GO:0030519) |
0.2 | 2.3 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.2 | 1.0 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.2 | 0.6 | GO:0008386 | cholesterol monooxygenase (side-chain-cleaving) activity(GO:0008386) |
0.2 | 0.2 | GO:0030627 | pre-mRNA 5'-splice site binding(GO:0030627) |
0.2 | 2.0 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.2 | 1.4 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.2 | 0.6 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.2 | 0.4 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
0.2 | 0.6 | GO:0033265 | choline binding(GO:0033265) |
0.2 | 0.2 | GO:0032551 | UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
0.2 | 9.1 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
0.2 | 3.6 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.2 | 0.4 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.2 | 100.8 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.2 | 0.2 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.2 | 0.4 | GO:0032090 | Pyrin domain binding(GO:0032090) |
0.2 | 0.5 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.2 | 0.3 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
0.2 | 1.4 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.2 | 2.0 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.2 | 7.8 | GO:0015485 | cholesterol binding(GO:0015485) |
0.1 | 1.9 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.1 | 2.3 | GO:0005504 | fatty acid binding(GO:0005504) |
0.1 | 0.1 | GO:0018812 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) |
0.1 | 0.1 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.1 | 0.7 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.1 | 0.5 | GO:0033797 | selenate reductase activity(GO:0033797) |
0.1 | 0.3 | GO:0004798 | thymidylate kinase activity(GO:0004798) |
0.1 | 0.4 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.1 | 1.4 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 0.3 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.1 | 0.1 | GO:0004031 | aldehyde oxidase activity(GO:0004031) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.1 | 0.1 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.1 | 2.0 | GO:0015149 | hexose transmembrane transporter activity(GO:0015149) |
0.1 | 1.0 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 6.1 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.1 | 1.1 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.1 | 1.2 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.1 | 1.7 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.1 | 0.6 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 0.2 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.1 | 1.5 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
0.1 | 0.5 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.1 | 0.7 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.0 | 0.2 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.0 | 1.4 | GO:0071617 | lysophospholipid acyltransferase activity(GO:0071617) |
0.0 | 0.1 | GO:0034979 | NAD-dependent protein deacetylase activity(GO:0034979) |
0.0 | 0.5 | GO:0016776 | phosphotransferase activity, phosphate group as acceptor(GO:0016776) |
0.0 | 2.7 | GO:0005516 | calmodulin binding(GO:0005516) |
0.0 | 13.4 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 1.6 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.0 | 0.1 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.0 | 27.2 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 1.2 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.4 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 0.1 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.0 | 0.1 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
0.0 | 0.0 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.0 | 0.1 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.2 | 5.2 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
4.9 | 9.8 | PID IGF1 PATHWAY | IGF1 pathway |
4.1 | 136.2 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
4.1 | 193.1 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
4.1 | 60.9 | PID EPHA FWDPATHWAY | EPHA forward signaling |
4.1 | 4.1 | PID IFNG PATHWAY | IFN-gamma pathway |
3.8 | 99.6 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
3.4 | 40.8 | PID S1P S1P4 PATHWAY | S1P4 pathway |
3.2 | 41.8 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
3.1 | 166.4 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
3.0 | 6.0 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
2.9 | 61.4 | PID EPHB FWD PATHWAY | EPHB forward signaling |
2.9 | 51.9 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
2.9 | 198.4 | PID REELIN PATHWAY | Reelin signaling pathway |
2.7 | 175.6 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
2.6 | 47.2 | PID S1P S1P1 PATHWAY | S1P1 pathway |
2.6 | 109.5 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
2.6 | 90.5 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
2.5 | 7.6 | PID NECTIN PATHWAY | Nectin adhesion pathway |
2.5 | 105.1 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
2.4 | 61.5 | ST GA12 PATHWAY | G alpha 12 Pathway |
2.3 | 46.3 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
2.3 | 90.1 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
2.3 | 81.3 | PID RAS PATHWAY | Regulation of Ras family activation |
2.3 | 49.6 | PID ARF 3PATHWAY | Arf1 pathway |
2.2 | 94.0 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
2.1 | 75.0 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
2.1 | 23.5 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
2.1 | 8.5 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
2.1 | 131.8 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
2.0 | 79.6 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
2.0 | 100.5 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
2.0 | 61.1 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
1.9 | 28.1 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
1.8 | 130.5 | PID LKB1 PATHWAY | LKB1 signaling events |
1.8 | 43.1 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
1.7 | 52.1 | ST G ALPHA I PATHWAY | G alpha i Pathway |
1.7 | 13.7 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
1.7 | 89.2 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
1.7 | 53.3 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
1.6 | 3.2 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
1.6 | 4.7 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
1.6 | 3.1 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
1.6 | 42.2 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
1.6 | 17.1 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
1.5 | 21.0 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
1.4 | 47.7 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
1.4 | 20.1 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
1.4 | 15.4 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
1.4 | 7.0 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
1.4 | 278.9 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
1.3 | 270.5 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
1.3 | 30.4 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
1.3 | 53.3 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
1.2 | 13.6 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
1.2 | 41.1 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
1.2 | 68.4 | PID BMP PATHWAY | BMP receptor signaling |
1.0 | 37.5 | PID CDC42 PATHWAY | CDC42 signaling events |
0.9 | 21.2 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.9 | 18.3 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.9 | 58.7 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.9 | 21.5 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.8 | 49.7 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.8 | 9.1 | ST STAT3 PATHWAY | STAT3 Pathway |
0.8 | 20.6 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.8 | 12.7 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.8 | 0.8 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.8 | 30.8 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.8 | 81.1 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.8 | 9.9 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.8 | 7.5 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.8 | 9.0 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.7 | 4.8 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.7 | 24.8 | PID FGF PATHWAY | FGF signaling pathway |
0.6 | 33.5 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.6 | 30.8 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.6 | 12.6 | PID ARF6 PATHWAY | Arf6 signaling events |
0.6 | 5.1 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.5 | 5.9 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.5 | 11.5 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.5 | 18.0 | NABA COLLAGENS | Genes encoding collagen proteins |
0.5 | 5.0 | PID ENDOTHELIN PATHWAY | Endothelins |
0.5 | 5.7 | PID INSULIN PATHWAY | Insulin Pathway |
0.5 | 10.9 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.4 | 7.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.4 | 7.6 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.4 | 5.9 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.4 | 8.8 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.4 | 6.3 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.4 | 1.8 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.3 | 1.7 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.3 | 104.3 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.3 | 1.6 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.3 | 82.4 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
0.3 | 8.6 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.2 | 0.4 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.2 | 0.4 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.2 | 2.6 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.2 | 1.2 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.2 | 0.5 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 1.6 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.1 | 0.5 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 1.7 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 0.5 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 4.1 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 0.5 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 1.5 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.0 | 0.3 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.4 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 0.1 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
11.6 | 197.8 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
11.3 | 270.8 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
9.6 | 229.7 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
9.1 | 145.3 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
6.6 | 105.3 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
6.5 | 215.0 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
6.4 | 76.5 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
6.3 | 44.4 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
6.2 | 130.3 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
6.1 | 387.4 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
6.0 | 84.0 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
5.8 | 93.0 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
5.3 | 74.2 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
5.2 | 62.5 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
4.9 | 237.5 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
4.8 | 14.5 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
4.8 | 101.3 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
4.8 | 226.3 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
4.7 | 102.7 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
4.6 | 223.0 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
4.5 | 91.0 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
4.4 | 88.0 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
4.4 | 148.4 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
4.0 | 48.0 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
3.4 | 97.4 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
3.2 | 73.9 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
3.2 | 6.4 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
3.2 | 76.3 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
3.2 | 9.5 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
3.1 | 21.9 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
3.1 | 40.6 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
3.1 | 71.8 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
3.1 | 119.3 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
3.1 | 52.0 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
3.0 | 99.9 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
3.0 | 29.6 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
2.9 | 11.7 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
2.8 | 59.2 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
2.8 | 164.7 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
2.7 | 45.7 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
2.7 | 230.4 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
2.6 | 62.0 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
2.6 | 82.3 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
2.6 | 40.9 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
2.5 | 33.1 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
2.5 | 126.8 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
2.5 | 12.4 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
2.4 | 68.3 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
2.4 | 79.5 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
2.4 | 16.7 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
2.4 | 73.1 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
2.3 | 58.0 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
2.3 | 22.9 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
2.3 | 59.2 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
2.2 | 96.2 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
2.1 | 31.5 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
2.1 | 41.8 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
2.1 | 18.7 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
2.0 | 24.4 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
2.0 | 34.5 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
2.0 | 72.5 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
2.0 | 35.5 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
1.9 | 57.6 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
1.9 | 3.8 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
1.9 | 137.9 | REACTOME NEURONAL SYSTEM | Genes involved in Neuronal System |
1.8 | 25.0 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
1.8 | 83.6 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
1.7 | 25.7 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
1.7 | 29.1 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
1.7 | 55.7 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
1.7 | 42.0 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
1.7 | 23.3 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
1.6 | 24.1 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
1.5 | 17.0 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
1.5 | 37.1 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
1.5 | 4.5 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
1.5 | 39.9 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
1.5 | 203.3 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
1.4 | 51.9 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
1.4 | 24.0 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
1.4 | 9.7 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
1.4 | 124.7 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
1.4 | 33.2 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
1.4 | 9.6 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
1.4 | 98.1 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
1.4 | 40.6 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
1.3 | 5.4 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
1.3 | 17.9 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
1.3 | 22.7 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
1.3 | 27.6 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
1.2 | 1.2 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
1.2 | 2.3 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
1.2 | 17.6 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
1.1 | 9.2 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
1.1 | 11.2 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
1.1 | 16.6 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
1.1 | 4.3 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
1.1 | 24.5 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
1.0 | 30.9 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
1.0 | 7.0 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
1.0 | 133.4 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
1.0 | 130.8 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
1.0 | 27.1 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
1.0 | 25.1 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
1.0 | 11.5 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
1.0 | 14.3 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.9 | 26.4 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.9 | 15.1 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.9 | 18.8 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.9 | 0.9 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.9 | 22.6 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.9 | 41.6 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.9 | 20.9 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.8 | 13.6 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.8 | 15.7 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.8 | 7.4 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.8 | 3.3 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.8 | 18.7 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.8 | 12.9 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.8 | 12.8 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.8 | 30.4 | REACTOME SIGNALING BY ERBB4 | Genes involved in Signaling by ERBB4 |
0.8 | 10.3 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.8 | 3.1 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.8 | 3.1 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.8 | 18.9 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.7 | 23.8 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.7 | 4.1 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.7 | 17.2 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.7 | 2.6 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.6 | 13.0 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.6 | 20.2 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.6 | 22.1 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
0.6 | 7.6 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.6 | 41.9 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.6 | 4.5 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.6 | 9.6 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.6 | 9.5 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.5 | 4.4 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.5 | 40.2 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.5 | 4.1 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.5 | 13.9 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.5 | 17.7 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.5 | 5.3 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.5 | 62.2 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.5 | 8.9 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.5 | 7.0 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.5 | 9.7 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.5 | 3.7 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.5 | 8.6 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.4 | 1.3 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.4 | 24.2 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.4 | 5.1 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.4 | 11.1 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
0.4 | 16.3 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.4 | 11.4 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.4 | 3.8 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.4 | 7.7 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.3 | 0.7 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.3 | 7.4 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.3 | 4.8 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.3 | 2.1 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.3 | 10.6 | REACTOME SIGNALING BY GPCR | Genes involved in Signaling by GPCR |
0.3 | 2.1 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.2 | 0.9 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.2 | 1.9 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.2 | 13.0 | REACTOME PI METABOLISM | Genes involved in PI Metabolism |
0.2 | 3.8 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.2 | 6.6 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
0.1 | 2.9 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.1 | 2.8 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.1 | 5.0 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.1 | 0.8 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.1 | 1.7 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.1 | 1.3 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.1 | 17.1 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 1.0 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.0 | 0.3 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 0.1 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |